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varying un sizes between 1/3 to 1/9 of the main nuclei. (B) 
BNC with three MNi touching, but not overlapping the 
main nuclei. (C) A BNC with nucleoplasmic bridge 
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between main nuclei and two MNi. (D) A BNC with six 
MNi varying in sizes (Fenech et al., 2003). 
 
Figure 2.6 Example of MTT assay. 96 well plate, in which the MTT 
solution was removed and the formazan solvent DMSO 
was added, resulting in a purple colour. 
 
37 
Figure 2.7 Mechanisms of flow cytometry. There are four general 
components of a flow cytometer: fluidics, optics, detectors 
and electronics. Cells in suspension flow in single-file 
through an illuminated volume, where they scatter light 
and emit fluorescence that is collected, filter and converted 
to digital numbers that are stored on a computer (Brown et 
al., 2002). 
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Figure 3.1 The absorption of each AuNP solution. UV-vis spectrum 
of both types of AuNPs was obtained using the Agilent 
8453. Absorbance profiles were measured between 525–
580 nm, with an SPR of 525 nm occurring for 5 nm AuNPs 
(A) and 10 nm AuNPs (B). The red vertical line represents 
the λmax at 525 nm and indicates the successful production 
of AuNPs. 
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Figure 3.2.1 Zeta (Z) potential measurements of 5 nm and 10 nm 
AuNPs.  The Z-potential of 5 (A) and 10 (B) nm AuNPs 
was -24.5 mV and -23.2 mV, respectively. The negative Z-
potential values present the necessary repulsive forces for 
the particles to remain stable in the solution. Nanoparticles 
with Z-potential < -30 mV are regarded as strongly anionic, 
whereas nanoparticles with a Z-potential > +30 mV are 
regarded as strongly cationic. Data was obtained in phase 
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analysis light scattering mode at 25 °C and pH 7.4 
(Addendum: Table 5.1). 
 
Figure 3.2.2 PDI represents the size distribution width, whereas 
DLS (Z-average) displays the hydrodynamic core size 
of both 5 and 10 nm AuNPs. A PDI value of 0.1–0.25 
suggests that the nanoparticles have a uniform size 
distribution, whilst a PDI > 0.5 indicates a very broad 
distribution. Results conducted shows that both sizes of 
AuNPs have a uniformity size width distribution. DLS 
measurements (Z-average) show that the 5 nm AuNPs are 
38.12 nm in diameter (A), whilst 10 nm AuNPs are 48.50 
nm in diameter (B). These larger sizes in diameter may be 
due to the agglomeration state of nanoparticles as a 
function of time or suspending solution. Data was obtained 
in phase analysis light scattering mode at 25 °C and pH 7.4 
(Addendum: Fig. 5.2). 
 
42 
Figure 3.3 TEM micrographs of 50 µg/ml of 10 nm AuNPs within 
MCF-7 cells (A–F) and within the MCF-10A cells (G–
L). A large number of vesicles transporting AuNPs were 
observed in the MCF-7 cells. After the 4 hour incubation 
period, some AuNPs were observed in the vicinity of the 
nucleus. Red arrows indicate the nuclear membrane of the 
cell, blue arrows indicate possible autophagosomes or 
transport vesicles, yellow arrows represents the 10 nm 
AuNPs, pink arrows shows swollen mitochondria and the 
green arrows indicate possible lysosomal bodies. The 
swollen mitochondria could possibly be due to AuNP 
induced cytotoxic stress. AuNPs are taken up by 
endocytosis which is clearly indicated by the orange arrows 
(J), (E) and (F), which indicates the distance from the 
AuNPs to the nuclear membrane; 0.12 µm, 0.15 µm and 
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0.49 µm, respectively. 0.01 µm TEM measurement of the 
AuNPs itself to illustrate that it is indeed 10 nm in diameter 
(G). AuNPs were observed in the nucleus (A and B), 
within the cells and near the nuclear membranes of the 
cells. The MCF-7 cells consistently displayed a greater 
number of AuNPs in the cells, in comparison to the MCF-
10A cells which displayed far less AuNPs. 
 
Figure 3.4 γ-H2AX foci assay. Examples of isolated human 
lymphocytes after the γ-H2AX foci assay, wherein (A–C) 
illustrates non-radiated control samples, (D–F) non-
radiated lymphocytes incubated with 5 nm AuNPs, (G–I) 
lymphocytes incubated irradiated with 5 nm AuNPs, (J–L) 
non-radiated lymphocytes incubated with 10 nm AuNPs 
and (M–O) lymphocytes incubated irradiated with 10 nm 
AuNPs. The blue area represents the isolated human 
lymphocyte and the green ‘dots’ shows the foci, which 
represent the amount of DNA DSBs in the cell. All 
samples were treated with 50 µg/ml of AuNPs and 
irradiated with 1 Gy X-rays.  
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Figure 3.5 Box-and-Whisker plot representing γ-H2AX foci in 
isolated lymphocytes. Box-and-Whisker plots represents 
the quantification of effects of isolated human lymphocytes 
incubated with culture media containing 50 µg/ml of 
AuNPs for 4 hours followed by 1 Gy X-rays and 1 Gy 
p(66)/Be neutron radiation, respectively. Significant 
increases (p < 0.000001) in foci are observed in the overall 
cell count compared to the control. * represents only two 
data points obtained for the p(66)/Be neutron radiation 
experiment (Addendum: Table 5.3). 
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Figure 3.6 CHO-K1 cells after CBMN assay, wherein (A) illustrates a 
BNC, (B) two BNC, each with one micronuclei (MNi), (C) 
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a characteristic apoptotic cell indicated via a blue arrow, 
(D) a BNC with one MNi, (E) a BNC with three MNi and 
(F) a BNC with four MNi. White arrows indicate MNi 
within BNCs.  
 
Figure 3.7 BEnd5 cells after CBMN assay, wherein (A) illustrates a 
two BNCs, (B) two mononucleated cells, and a BNC with 
one MNi, (C) and (D) a BNC with one MNi, (E) a 
mononucleated cell, and a BNC with three MNi and (F) 
two BNC, one with two MNi. White arrows indicate MNi 
within BNCs. 
 
47 
Figure 3.8 MCF-7 cells after CBMN assay, wherein (A) illustrates a 
BNC, (B) a BNC with three MNi, (C) two BNC with four 
and five MNi, respectively, (D) a BNC with an anaphase 
bridge between the cells, (E) a BNC and a possible 
apoptotic cell and (F) a BNC with multiple MNi. White 
arrows indicate MNi within BNCs, blue arrow indicates a 
characteristic apoptotic cell and pink arrows indicate an 
anaphase bridge. 
 
48 
Figure 3.9 MCF-10A cells after CBMN assay, wherein (A) illustrates 
two BNCs, (B) a BNC with two MNi, (C) two BNCs, (D) a 
BNC, (E) a mononucleated cell, and a BNC with three 
MNi and (F) a BNC with one MNi. White arrows indicate 
MNi within BNCs and the pink arrow indicate an anaphase 
bridge. 
 
48 
Figure 3.10 CHO-K1 cells after CBMN assay, wherein (A) illustrates a 
BNC, (B) a BNC with multiple MNi, (C) a BNC with two 
MNi, (D) a BNC, and (E) and (F) a BNC with multiple 
MNi. White arrows indicate MNi within BNCs, the blue 
arrow illustrates a characteristic apoptotic cell and yellow 
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arrow indicates cell blebbing.  
 
Figure 3.11 MCF-7 cells after CBMN assay, wherein (A) illustrates a 
BNC, (B) four BNCs with multiple MNi, (C) a BNC with 
two MNi, (D) a BNC with four MNi, (E) a BNC with two 
MNi, and (F) two distinctive apoptotic cells. White arrows 
indicate MNi within BNCs, the blue arrow illustrates a 
distinctive apoptotic cell and pink arrow indicates an 
anaphase bridge.  
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Figure 3.12 CHO-K1 cells after CBMN assay, wherein (A) illustrates 
two BNCs, (B) two BNCs; one with one MNi, (C) two 
BNC, and a cell in prometaphase, (D) and (E) four BNC, 
and (F) a BNC with one MNi, and a cell in early anaphase. 
White arrows indicate MNi within BNCs, the blue arrows 
indicate distinctive apoptotic cells, orange arrows indicate 
metaphases, and the purple arrow shows that the cells are 
pyktonic.   
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Figure 3.13 MCF-7 cells after CBMN assay, wherein (A) illustrates 
two BNCs, (B) a BNC with two MNi, (C) two BNCs, (D) 
two BNCs; one with one MNi, (E) six BNCs, (F) three 
BNCs; one with two MNi. White arrows indicate MNi 
within BNCs and the pink arrow points to an anaphase 
bridge.   
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Figure 3.14 CHO-K1 cells after CBMN assay, wherein (A) illustrates 
three BNCs, (B) three BNCs; one with three MNi, (C) and 
(D) a BNC with one MNi, and (E) and (F) a BNC with an 
anaphase bridge between the cells.  White arrows indicate 
MNi within BNCs, a yellow arrow shows blebbing of the 
cell and pink arrow shows a distinctive anaphase bridge. 
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Figure 3.15 MCF-7 cells after CBMN assay, wherein (A) illustrates 
two BNCs, (B) a BNC with different sizes of MNi, (C) 
BNCs with one MNi and one without MNi, (D) two BNCs, 
both containing two MNi, (E) a BNC with four MNi, and 
(F) three BNCs with various sizes and quantities of MNi. 
White arrows indicate MNi within BNCs and the pink 
arrow shows a distinctive anaphase bridge. 
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Figure 3.16 CHO-K1 cells after CBMN assay, wherein (A) illustrates 
three BNCs, (B) multiple apoptotic cells, (C) and (D) 
BNCs with one MNi, (E) a BNC with multiple MNi, and 
(F) a BNC with four MNi. White arrows indicate MNi 
within BNCs and blue arrows indicate possible apoptotic 
events.  
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Figure 3.17 MCF-7 cells after CBMN assay, wherein (A) illustrates 
two BNCs, (B) a number of MNi with BNCs, (C) two 
BNCs; one cell containing one MNi, (D) two BNCs both 
having two MNi, (E) a number of MNi with BNC, and (F) 
two BNCs with two and four MNi, respectively. White 
arrows indicate MNi within BNCs and the pink arrow 
indicates an anaphase bridge.  
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Figure 3.18 (A) Cellular kinetics of the CHO-K1 cells was determined 
by scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 2 Gy X-rays showed an overall decrease in 
cellular kinetics in comparison to the control. (B) Mean 
cumulative frequency of MNi present determined via the 
CBMN assay in CHO-K1 cells after 4 hour incubation with 
50 µg/ml AuNPs followed by 2 Gy X-ray radiation. 
Control cells treated with AuNPs showed a small number 
of MNi, whilst an outspoken increase of MNi within cells 
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treated with AuNPs and radiated with 2 Gy X-rays was 
apparent. The interaction indices for AuNPs and 6 MV X-
rays in CHO-K1 cells are 1.6 to 1.7, thus > Unity (Unity = 
1). 
 
Figure 3.19 (A) Cellular kinetics of the BEnd5 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 2 Gy X-rays showed an overall decrease in 
cellular kinetics in comparison to the control. (B) Mean 
cumulative frequency of MNi present determined via the 
CBMN assay in BEnd5 cells after 4 hour incubation with 
50 µg/ml AuNPs followed by 2 Gy X-ray radiation. 
Control cells treated with AuNPs showed a negligible 
number of MNi, whilst a noticeable increase of MNi within 
cells treated with AuNPs and radiated with 2 Gy X-rays 
was apparent. The interaction indices for AuNPs and 6 MV 
X-rays of 0.92 to 1.06 determined for BEnd5 cells was 
differed from Unity (Unity = 1). 
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Figure 3.20 (A) Cellular kinetics of MCF-7 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 2 Gy X-rays showed an overall decrease in 
cellular kinetics in comparison to the control. (B) Mean 
cumulative frequency of MNi present determined via the 
CBMN assay in MCF-7 cells after 4 hour incubation with 
50 µg/ml AuNPs followed by 2 Gy X-ray radiation. 
Control cells treated with AuNPs displayed an insignificant 
number of MNi, whilst an outspoken increase of MNi 
within cells treated with AuNPs and radiated with 2 Gy X-
rays was apparent. The interaction indices for AuNPs and 6 
MV X-rays of 1.3 to 1.4 were determined for MCF-7 cells, 
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which is > Unity (Unity = 1). 
 
Figure 3.21 (A) Cellular kinetics of MCF-10A cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs, 
excluding cells treated with 10 nm AuNPs and/or irradiated 
with 2 Gy X-rays showed an overall decrease in cellular 
kinetics in comparison to the control. (B) Mean cumulative 
frequency of MNi present determined via the CBMN assay 
in MCF-10A cells after 4 hour incubation with 50 µg/ml 
AuNPs followed by 2 Gy X-ray radiation. Control cells 
treated with AuNPs showed an insignificant number of 
MNi in control, whilst a noticeable increase of MNi within 
cells treated with AuNPs and radiated with 2 Gy X-rays 
was apparent. The interaction indices for AuNPs and 6 MV 
X-rays of 0.87 to 0.97 determined for MCF-10A cells, 
which is < Unity (Unity = 1). 
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Figure 3.22 (A) Cellular kinetics of CHO-K1 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 4 Gy X-rays showed an overall decrease in 
cellular kinetics in comparison to the control. (B) Mean 
cumulative frequency of MNi present determined via the 
CBMN assay in CHO-K1 cells after 4 hour incubation with 
50 µg/ml AuNPs followed by 4 Gy X-ray radiation. 
Control cells treated with AuNPs caused an insignificant 
number of MNi, whilst a clear increase of MNi within cells 
treated with AuNPs and radiated with 4 Gy X-rays was 
observed. The interaction indices for AuNPs and 6 MV 4 
Gy X-rays of 1.04 to 1.13 have been determined for CHO-
K1 cells is lower than the interaction indices after 2 Gy, in 
comparison to 2 Gy X-rays. 
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Figure 3.23 (A) Cellular kinetics of MCF-7 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 4 Gy X-rays showed an overall decrease in 
cellular kinetics in comparison to the control. (B) Mean 
cumulative frequency of MNi present determined via the 
CBMN assay in MCF-7 cells after 4 hour incubation with 
50 µg/ml AuNPs followed by 4 Gy X-ray radiation. 
Control cells treated with AuNPs displayed a few caused 
MNi, whilst an observable increase of MNi within cells 
treated with AuNPs and radiated with 4 Gy X-rays was 
apparent. The interaction indices for AuNPs and 4 Gy X-
rays of 0.74 to 0.77 is lower than the interaction indices 
after 2 Gy X-rays. 
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Figure 3.24 (A) Cellular kinetics of CHO-K1 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 2.5 µg/ml AuNPs and/or 
irradiated with 2 Gy X-rays showed no change in cellular 
kinetics in comparison to the control. (B) Mean cumulative 
frequency of MNi present determined via the CBMN assay 
in CHO-K1 cells after 4 hour incubation with 2.5 µg/ml 
AuNPs followed by 2 Gy X-ray radiation. The radiated 
samples treated with AuNPs showed a number of MNi, but 
no difference between the control and the AuNP treated 
samples were observed. The interaction indices for AuNPs 
and 2 Gy X-rays of 0.89 to 1.00 is lower than the 
interaction indices after 50 µg/ml AuNPs. 
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Figure 3.25 (A) Cellular kinetics of MCF-7 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 2.5 µg/ml AuNPs and/or 
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irradiated with 2 Gy X-rays showed no change in cellular 
kinetics in comparison to the control. (B) Mean cumulative 
frequency of MNi present determined via the CBMN assay 
in MCF-7 cells after 4 hour incubation with 2.5 µg/ml 
AuNPs followed by 2 Gy X-ray radiation. A visible 
increase of MNi within cells treated with AuNPs and 
radiated with 2 Gy X-rays was evident in comparison to the 
radiated control. The interaction indices for AuNPs and 2 
Gy X-rays of 1.10 to 1.19 are lower than the interaction 
indices after 50 µg/ml AuNPs. 
 
Figure 3.26 (A) Cellular kinetics of CHO-K1 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 1 Gy p(66)/Be neutrons showed an overall 
decrease in cellular kinetics in comparison to the control. 
(B) Mean cumulative frequency of MNi present were 
determined via the CBMN assay in CHO-K1 cells after 4 
hour incubation with 50 µg/ml AuNPs followed by 1 Gy 
p(66)/Be neutrons. Control cells treated with AuNPs 
displayed an insignificant number of MNi, whilst a visible 
increase of MNi within cells treated with AuNPs and 
radiated with 1 Gy p(66)/Be neutrons was evident. The 
interaction indices for AuNPs and 1 Gy p(66)/Be neutrons 
of 1.06 to 1.16 is lower than the interaction indices after 2 
X-rays. 
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Figure 3.27  (A) Cellular kinetics of MCF-7 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs 
showed a decrease in cellular kinetics in comparison to the 
control, whilst the irradiated cells with 1 Gy p(66)/Be 
neutrons did not differ from the radiated control. (B) Mean 
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cumulative frequency of MNi present determined via the 
CBMN assay in MCF-7 cells after 4 hour incubation with 
50 µg/ml AuNPs followed by 1 Gy p(66)/Be neutrons. No 
difference in the number of MNi within cells treated with 
AuNPs and radiated with 1 Gy p(66)/Be neutrons and the 
radiated control was noticeable. The interaction indices for 
AuNPs and 1 Gy p(66)/Be neutrons of 0.88 to 0.95 is lower 
than the interaction indices after 2 Gy X-rays. 
 
Figure 3.28 (A) Cellular kinetics of CHO-K1 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 2 Gy p(66)/Be neutrons showed an overall 
decrease in cellular kinetics in comparison to the control. 
(B) Mean cumulative frequency of MNi present determined 
via the CBMN assay in CHO-K1 cells after 4 hour 
incubation with 50 µg/ml AuNPs followed by 2 Gy 
p(66)/Be neutrons. All the samples radiated with 2 Gy 
p(66)/Be neutrons showed an increase in the number of 
MNi, however no clear increase was observed in the 
samples treated with AuNPs. The interaction indices for 
AuNPs and 2 Gy p(66)/Be neutrons of 1.00 to 1.02 is lower 
than he interaction indices after 2 Gy X-rays.   
 
66 
Figure 3.29 (A) Cellular kinetics of MCF-7 cells was determined by 
scoring 400 AO stained BNCs and expressed as a 
percentage (%). Cells treated with 50 µg/ml AuNPs and/or 
irradiated with 2 Gy p(66)/Be neutrons showed a small 
decrease in cellular kinetics in comparison to the control. 
(B) Mean cumulative frequency of MNi present determined 
via the CBMN assay in MCF-7 cells after 4 hour 
incubation with 50 µg/ml AuNPs followed by 2 Gy 
p(66)/Be neutrons. Control cells treated with AuNPs 
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showed an irrelevant number of MNi. No difference 
between the radiated control and the AuNPs samples after 
2 Gy p(66)/Be neutrons – was obvious. The interaction 
indices for AuNPs and 2 Gy p(66)/Be neutrons of 0.86 to 
0.94 is lower than the interaction indices after 2 Gy X-rays.  
 
Figure 3.30 Box-and-Whisker plots showing the % cell viability in 
CHO-K1 cells as determined by MTT in 96 well plates. 
(A) Cells incubated with AuNPs for 4 hours, (B) cells 
incubated with AuNPs for 4 hours followed by 4 Gy 6 MV 
X-ray radiation, and (C) cells incubated with AuNPs for 24 
hours. 5 and 10 nm AuNPs, at 50 µg/ml, caused a 
significant decrease in cell proliferation (p < 0.05) in all 
three different conditions, namely A, B and C (Addendum: 
Tables 5.4–5.6). 
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Figure 3.31 Box-and-Whisker plots showing the % cell viability in 
CHO-K1 cells as determined by MTT in 96 well plates. 
(A) Cells incubated with AuNPs for 4 hours, (B) cells 
incubated with AuNPs for 4 hours followed by 4 Gy X-ray 
radiation, and (C) cells incubated with AuNPs for 24 
hours. 5 and 10 nm AuNPs, at 50 µg/ml, caused a 
significant decrease in cell proliferation (p < 0.05) in all 
three different conditions, namely A, B and C (Addendum: 
Tables 5.7–5.9). 
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Figure 3.32 Box-and-Whisker plots showing the % cell viability in 
MCF-7 cells as determined by MTT in 96 well plates. 
(A) Cells incubated with AuNPs for 4 hours, (B) cells 
incubated with AuNPs for 4 hours followed by 4 Gy X-ray 
radiation, and (C) cells incubated with AuNPs for 24 
hours. 5 and 10 nm AuNPs, at 50 µg/ml, caused a 
significant decrease in cell proliferation (p < 0.05) in all 
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three different conditions, namely A, B and C (Addendum: 
Tables 5.10–5.12).  
 
Figure 3.33 Box-and-Whisker plots showing the % cell viability in 
MCF-10A cells as determined by MTT in 96 well plates. 
(A) Cells incubated with AuNPs for 4 hours, (B) cells 
incubated with AuNPs for 4 hours followed by 4 Gy X-ray 
radiation, and (C) cells incubated with AuNPs for 24 
hours. 5 and 10 nm AuNPs, at 50 µg/ml, caused a 
significant decrease in cell proliferation (p < 0.05), except 
in condition C (Addendum: Tables 5.13–5.15). 
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Figure 3.34 Flow cytometry was used to investigate the cell cycle 
progression in CHO-K1 cells. The DNA histograms show 
the effect of AuNPs on the CHO-K1 cells after a 4 hour 
exposure period, followed by 2 Gy X-ray radiation. (A) 
non-radiated control, (B) irradiated control, (C) non-
radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 
50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells 
with 50 µg/ml of 10 nm AuNPs and (F) cells with 50 
µg/ml irradiated 10 nm AuNPs. 
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Figure 3.35 Flow cytometry was used to investigate the cell cycle 
progression in BEnd5 cells. The DNA histograms show 
the effect of AuNPs on the BEnd5 cells after a 4 hour 
exposure period, followed by 2 Gy X-ray radiation. (A) 
non-radiated control, (B) irradiated control, (C) non-
radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 
50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells 
with 50 µg/ml of 10 nm AuNPs and (F) cells with 50 
µg/ml irradiated 10 nm AuNPs. 
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progression in MCF-7 cells. The DNA histograms show 
the effect of AuNPs on the MCF-7 cells after a 4 hour 
exposure period, followed by 2 Gy X-ray radiation. (A) 
non-radiated control, (B) irradiated control, (C) non-
radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 
50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells 
with 50 µg/ml of 10 nm AuNPs and (F) cells with 50 
µg/ml irradiated 10 nm AuNPs. 
 
Figure 3.37 Flow cytometry was used to investigate the cell cycle 
progression in MCF-10A cells. The DNA histograms 
show the effect of AuNPs on the MCF-10A cells after a 4 
hour exposure period, followed by 2 Gy X-ray radiation. 
(A) non-radiated control, (B) irradiated control, (C) non-
radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 
50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells 
with 50 µg/ml of 10 nm AuNPs and (F) cells with 50 
µg/ml irradiated 10 nm AuNPs. 
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Figure 5.1 Expert advice for the zeta potential measurements of 
AuNPs using Malvern Instruments’ Zetasizer Nano ZS. 
(A) represents the 5 nm AuNPs and (B) the 10 nm AuNPs. 
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Figure 5.2 Expert advice for the size measurements of AuNPs 
using Malvern Instruments’ Zetasizer Nano ZS. (A) 
represents the 5 nm AuNPS and (B) the 10 nm AuNPs. 
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ABSTRACT 
 
 
 
Despite the advances in therapies such as chemotherapy and radiotherapy, tumours have been 
shown to be resistant to the treatments. Gold nanoparticles (AuNPs) have been recognized as 
effective radiosensitizers of low energy (e.g. 200–500 kV) X-rays, leading to the emission of 
Auger electrons that cause highly localised ionizing damage to cells.  
 
Spherical AuNPs were synthesised via the reduction of the chloroaurate ions by sodium 
citrate. Characterisation of AuNPs involved UV-visible spectrophotometry, zeta (Z) potential, 
dynamic light scattering (DLS) and polydispersity index (PDI) measurements for 
determination of surface plasmon resonance (SPR), surface charge and stability, as well as 
transmission electron microscopy (TEM) for hydrodynamic core sizes, size distribution width 
and shape of AuNPs. Both the 5 and 10 nm AuNPs were found to be anionic with λmax 
absorbance of 525 nm and uniform size distribution. DLS measurement at 38.12 nm and 
48.50 nm, respectively for 5 nm and 10 nm AuNPs, points to aggregation of the AuNPs. 
However, TEM measurements confirmed the core size of the 10 nm AuNPs. Non-malignant 
Chinese hamster ovary (CHO-K1), brain endothelial (BEnd5), breast (MCF-10A), isolated 
human lymphocytes and malignant breast (MCF-7) cell lines were treated with 50 µg/ml of 
AuNPs, and irradiated with either 1, 2 or 4 Gy X-rays or 1 or 2 Gy p(66)/Be neutron 
radiation. The γ-H2AX foci assay, cytokinesis-block micronucleus assay, MTT assay and  
fluorescence-activated cell sorting (FACS) was used to determine that amount of double 
stranded breaks (DSBs) in isolated lymphocytes, the presence and number of micronuclei 
(MNi) within binucleated cells (BNCs), cell viability and cell cycle progression, respectively.  
 
Preliminary experiments that established the reliability of the study regarding the induction of 
DNA damage after the bombardment of AuNPs by scattered low kV X-rays, were carried out 
on lymphocytes. Combined treatment (AuNPs and radiation) resulted in more endogenous 
foci in comparison to lymphocytes that were treated with AuNPs only. The CHO-K1 and 
MCF-7 cells showed higher MNi frequencies after the combination treatment of AuNPs and 
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radiation compared to the number of MNi in samples exposed to AuNPs and radiation 
separately. The AuNPs alone influenced the cellular kinetics of all cell types. Interaction 
indices, which is the enhancement factor of AuNPs in combination with radiation, for AuNPs 
and 6 MV 2 Gy X-rays of 1.6 to 1.7 and 1.3 to 1.4 have respectively been determined for 
CHO-K1 and MCF-7 cells, whilst that for the other cell types used in the study were not 
different from Unity. As expected, the interaction indices between AuNPs and p(66)/Be 
neutrons was lower than the interaction indices after 2 Gy X-rays, as p(66)/Be neutrons 
interact only with the nuclei of the AuNP’s atoms and the X-ray photons interact with the 
orbital electrons of the atoms of the AuNPs leading to Auger electron emission.  
 
The cell viability assay showed that 50 µg/ml of AuNPs had an inhibitory effect on cellular 
proliferation, in all four cell linnes whereas the lower concentrations (2.5, 5 and 10 µg/ml) 
had no effect. Results in this study, revealed an increase in the accumulation of CHO-K1 an 
MCF-7 cells in the G2/M phase of the cell cycle after being treated with AuNPs followed by 
X-ray radiation, suggesting that the cells have possibly been sensitised to the damaging 
effects of radiation. Further studies are required to quantify internalised AuNPs and to then 
link the possible concentration differences of the AuNPs to differences in radiation damage 
effects observed for the different cell types. 
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CHAPTER 1: 
LITERATURE REVIEW 
 
 
 
1.1 Nanotechnology  
 
Nanotechnology is a promising field that involves the deliberate engineering of materials at 
the atomic or molecular level to create new materials, known as nanomaterial or 
nanoparticles that have unique and novel properties. Nanoparticles are defined as materials 
with external dimensions in the size range of approximately 1 - 100 nanometer (Fig. 1.1) 
(Oberdörster, 2010).  
 
.   
 
 
 
 
 
 
 
 
Figure 1.1: Logarithmical length scale showing size of nanoparticles compared to 
biological components and description of 'nano' and 'micro' sizes. Relative sizes of 
nanoparticles compared to common biological structures. Diagram of nanoparticle size as 
compared to common biological structures and their linked length scale. An electron 
microscope is required to envision structures that are submicrometer in size (Ediriwickrema & 
Saltzman, 2015). 
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Research in the use of nanoparticles for targeted drug delivery, detection and treatment of 
cancer is motivated by the unique features, such as surface to mass ratio that is much larger 
than that of other particles, their quantum properties, and the ability of the nanoparticles to 
increase interaction between the themselves and the surface of cells (De Jong & Borm, 2008; 
Lim et al., 2013; Verma et al., 2014).  
 
Nanoparticles can be engineered and created to encompass specific sizes, shapes, surface 
properties, stability and several other characteristics for a variety of applications, such as 
effective and targeted delivery of drugs and enhancing imaging techniques by infiltrating the 
biological, biophysical and biomedical barriers (Cai & Chen, 2007; Cai, et al., 2008). 
Research is moving towards the use of modern nanodevices, such as nanochips and 
nanosensors (Grodzinski et al., 2006; Sahoo et al., 2007), but studies on their 
biocompatibility, in vivo kinetics, acute and chronic toxicity, and competence to escape the 
reticuloendothelial system (RES) are on-going challenges that still have to be overcome by 
nanotechnology (Panchangam & Dutta, 2015). 
 
The nanoparticles mostly studied in biomedical applications, include quantum dots (Gao et 
al., 2004; Michalet et al., 2005), carbon nanotubes (Zhang et al., 2009; Elhissi et al., 2012), 
paramagnetic nanoparticles (Neuberger et al., 2005), liposomes (Cho et al., 2008; Malam et 
al., 2009) and gold nanoparticles (AuNPs) (Huang et al., 2007; Tiwari et al., 2011) (Fig. 1.2). 
 
 
 
 
 
 
 
 
Figure 1.2: Examples of nanoparticles. Several 
nanoparticles have been scrutinized for biomedical 
applications targeting cancer (Cai et al., 2008). 
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1.2 Gold nanoparticles (AuNPs) 
 
1.2.1 History of gold 
 
Dykman and Khlebtsove (2011) reported that the first data on colloidal gold can be found in 
dissertations by Chinese, Arabian, and Indian scientists, who obtained colloidal gold in the 
V–IV centuries BC. Scientists used gold (Au) for medical purposes, while alchemists used it 
to introduce prominent red colours to glass. An example of this is the Lycurcus Cup in the 
British Museum (Heiligtag & Niederberger, 2013) that is observed as a green in daylight 
(Fig. 1.3, left), but changes to a red colour (Fig. 1.3, right), when illuminated from the inside. 
Colloidal gold also known as AuNPs (Rohiman et al., 2011) are exceptionally small parts of 
gold which cannot be seen with the naked eye. Due to the small size they display a different 
colour from normal gold (Eustis and El-Sayed, 2005). 
 
 
 
 
 
 
 
 
 
 
 
1.2.2 Gold as medicine 
 
The element, gold has a long medical history, used for people suffering from nervous 
conditions (Fricker & Buckley, 1996), epilepsy in the 16
th
 century, syphilis (Daniel & Astruc, 
2004), tuberculosis (TB) in the beginning of the 19
th
 century, and in 1925 gold complexes 
Figure 1.3: The Lycurus Cup. This cup was designed and 
made by Romans in the 40th century (Heiligtag & 
Niederberger, 2013). 
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were being used to treat arthritis of all types especially, rheumatic diseases (Aaseth et al., 
1998; Kean et al., 1987; Shaw, 1999; Shedbalkar et al., 2014). A number of side effects have 
been linked with prolonged exposure to gold complex drugs, which include nephrotoxicity, 
skin irritation, mouth ulcers, liver toxicity and blood disorders (Bhattacharya & Mukherjee, 
2008). However, currently a second generation gold drug, auranofin (AF) used to treat 
rheumatoid arthritis, with limited adverse side effects and increased efficacy has been 
produced (Glennes et al., 1997; Daniel & Astruc, 2004; Panyala et al., 2009). 
 
1.2.3 Synthesis of AuNPs 
 
The synthesis of spherical AuNPs is performed via citrate reduction method applications, 
known as the Turkevich method (Turkevich et al., 1951; DiScipio, 1996). Chloroaurate ions 
are reduced by sodium citrate at 100°C (Fig. 1.4) resulting in the synthesis of monodispersed 
spherical AuNPs, which are electrostatically stabilised by citrate ions bound to surface of 
AuNPs. Size variation of AuNPs can be achieved by changing the temperature and/or 
gold/reducing agents’ ratios; with smaller particles yielded as the amount of reducing agents 
increases (Frens, 1875; Turkevich et al., 1951; Verma et al., 2014). Various other types of 
AuNPs exist, namely nanorods, nanoshells, nanocages, nanosphere, and Surface Enhanced 
Raman Scattering (SERS) nanoparticles (Cai et al., 2008). 
 
 
 
 
 
 
1.2.4 Characterisation and properties of AuNPs 
 
The AuNPs are generally characterised via UV-visible (vis) spectrophotometry, zeta (Z) 
potential measurements, dynamic light scattering (DLS), polydispersity index (PDI) and 
transmission electron microscopy (TEM) (Chithrani et al., 2006; Torres-Chavolla et al., 
Figure 1.4: Synthesis equation for synthesis of AuNPs. Schematic representation of 
reduction of the chloroaurate ions by sodium citrate at 100°C (Faraday, 1875) to produce 
AuNPs. 
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2010). The absorption of AuNP solution is measured via UV-vis spectrophotometry as a 
single absorption peak in the visible range between 510 – 550 nm, for the analysis of surface 
plasmon resonance (SPR) to determine AuNPs presence. AuNPs exhibit unique optical 
properties, which include SPR and the ability to bind amine and thiol groups, allowing 
surface modification and use in biomedical applications (Aillon et al., 2009). When AuNPs 
are excited by a specific wavelength of light, it will cause the conduction of electrons on the 
surface of the particles surface and will lead to SPR, whilst 2 nm AuNPs do not display SPR 
(Eustis & El-Sayed, 2005; Huang & EI-Sayed, 2010). Z-potential measurements reveal the 
stability of any nanoparticles in suspension. Z-potential measurements between -10 and +10 
mV are regarded as neutral, whilst Z-potential of > +30 mV or < -30 mV suggest that the 
nanoparticles are strongly cationic and strongly anionic, respectively (Clogston & Partri, 
2011; Abbott, 2014). An extremely positive or negative zeta potential value can cause larger 
repulsion forces whereas repulsion between particles with analogous electrical charge 
prevents aggregation (Honary & Zahir, 2013). The DLS technique can be used to determine 
the hydrodynamic size of small particles in suspension. The PDI represents the size 
distribution width of the AuNPs. A PDI value of 0.1–0.25 suggests that the nanoparticles 
possess uniform size distribution, while a PDI value greater than 0.5 indicates a very broad 
distribution and aggregation (Yeo, 2013). It is essential to maintain the PDI parameter as low 
as possible, to accomplish long-term stability of the AuNP solution.  
 
The size and shape of synthesised nanoparticles, quantum mechanics, electric, optical and 
chemical characteristics, can vary considerably from that of bulk solids (Burda et al., 2005).  
In addition, minor divergence in the size and shape of the AuNPs can have major effects on 
the properties of AuNPs. The behavior of the AuNPs depends on the ratio of surface area: as 
the ratio of surface area to volume increase, the behavior of the surface atoms assumes 
dominance over the composition of the nanoparticles itself (Arvizo et al., 2010; Yah, 2013).  
 
AuNPs have been consistently described as both non-toxic (Connor et al., 2005; Shukla et al., 
2005) and toxic (Goodman et al., 2004; Pernodet et al., 2006; Pan et al., 2007; Zhang et al., 
2011), depending on the size and surface charge of these nanoparticles. Pan et al. (2007) 
reported that the size of AuNPs plays a major role in toxicity and found that 15 nm AuNPs 
are non-toxic at all concentrations, whilst 1–2 nm AuNPs     cause rapid cell death by 
necrosis at low concentrations. Furthermore, AuNPs smaller than 4–5 nm in diameter may be 
toxic due to their ability to penetrate the nuclear membrane of the cell (Soenen et al., 2011). 
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Panyala and colleagues (2009) reported that metallic Au is non-toxic, however gold chloride 
or potassium gold cyanide is toxic to organs. Despite reports that cationic AuNPs are more 
toxic than anionic AuNPs (Wang et al., 2011; Logan & Ly, 2013), other researchers have 
shown that both cationic and anionic AuNPs are toxic to cells (Schaeublin et al., 2011), and 
that both positively and negatively charged AuNPs can induce alterations of the 
mitochondrial membrane leading to oxidative stress (Schaeublin et al., 2011).  
 
1.2.5 In vitro and in vivo studies 
 
In vitro studies of AuNPs are dissimilar in cell types, whereas in vivo studies examine 
toxicity to a disease, bio-imaging, possible routes of administration, biodistrubtion, 
translocation and clearance of AuNPs (Alkilany & Murphy, 2010; Khlebtsov & Dykman, 
2011; Verma et al., 2014). Freese and co-workers (2012), showed that the cell viability and 
the proliferation of endothelial cells decreased after exposure to AuNPs, particularly at high 
concentrations. A study by Chen et al. (2013) administered 21 nm AuNPs intravenously into 
mice models to investigate the distribution, organ toxicity and changes in inflammatory 
cytokines within the adipose tissue after AuNPs exposure. They reported no measureable 
organ or cell toxicity in the mice, but considerable fat loss and suppression of inflammation 
was observed due to the reducing agent sodium citrate. Therefore, to comprehend the 
chemical and physical interaction of AuNPs with biological media is of great importance to 
establish suitable biological models to investigate cytotoxic effects. 
 
1.3 Cancer 
 
According to World Health Organisation (WHO) (2008), cancer is the primary cause of death 
in economically developed countries and the second leading cause of death in developing 
countries. Miller et al. (2016) reported that the 3 most common cancers in 2016 were prostate 
(3 306 760), colon and rectum (724 690), and melanoma (614 460) amongst males in the 
United States of America (USA). Amongst females it was breast (3 560 570), uterine corpus 
(757 190), and colon and rectum (727 350) (Miller et al., 2016). South Africa is one of the 
countries with the highest cancer incidence and prevalence on the World Cancer Research 
Fund’s list of countries (Fourie et al., 2014). As a consequence of population aging and 
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growth, with an increase in cancer-associated lifestyle choices, such as smoking, alcohol 
consumption, physical inactivity and unhealthy diets, the burden of cancer is rising in 
economically developing countries. It is predicted that a 78% increase in cancer cases by 
2030 can be expected (Morhason-Bello et al., 2014). Despite our knowledge and advances in 
cancer biology, the personal and economic burden of cancer is escalating, which emphasizes 
the critical need for intensified research efforts in developing treatments. 
 
1.3.1 Breast cancer 
 
In 2016, 1 685 210 new cancer cases and 595 690 cancer deaths were estimated to occur in 
the United States (US) (Siegel et al., 2016). According to the American Cancer Society 
(2016), the most common type of cancer is breast cancer, with more than 249 000 cases being 
expected in US. Breast cancer is the second leading cause of cancer death after lung cancer 
amongst African American women. Regardless of all the improvements that have been made 
in the area of breast cancer research, African American women suffer excessively from the 
effects of this disease (Jones & Chilton, 2002; Jemal et al., 2011). Miller et al. (2016) 
reported worldwide that 75% of breast cancer survivors are of 60 years or older, whilst 7% 
are younger than 50 years; 19% of breast cancers are diagnosed in women aged of 30 to 49 
years, and 44% occur amongst women who are 65 years or older.  
 
According to Jemal et al. (2011) and the American Cancer Society (2013), breast cancer 
mortality among African American women is nearly 28% higher than in White women.  This 
difference between the mortality rates of African American and White women can be related 
to a later stage of diagnosis or being diagnosed with an aggressive estrogen receptor tumour 
in African American women. Furthermore, black women have a lower survival rate within 
each stage due a slighter chance to be diagnosed at a local breast cancer stage, compared to 
white women (53% versus 62%) (Howlander et al., 2015). This is due to diversity of 
socioeconomic concerns and difference in comorbidities, lack of premium medical care  
among black women, and biological variations in cancers (e.g. higher occurrence of triple 
negative cancer in black women) (Curtis et al., 2008; Vona-Davis & Rose, 2009; Danforth et 
al., 2013). 
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The common risk factors that may be linked to the development of breast cancer include: 
alcohol abuse, cigarette smoke, early menstruation, lack of exercise and obesity which also 
affects the prognosis of breast cancer (Chen et al., 2011). Besides lifestyle and environmental 
factors, there are a number of genes that may contribute toward the development of breast 
cancer. These genes include the BReast CAncer (BRCA) 1 and BRCA 2 gene. It is believed 
that 5–10% of breast cancers are hereditary and caused by mutations in the BRCA 1 and 
BRCA 2 genes (Apostolou & Fostira, 2013). BRCA 1 and BRCA 2 are human genes that 
produce tumour suppressor proteins and participate in the repair of damaged 
deoxyribonucleic acid (DNA) to maintain the stability of the cell’s genetic material (Welcsh 
& King, 2001; Silver & Livingston, 2012). A mutation in the BRCA 1/2 genes, inhibits the 
DNA repair process leading to unchecked cell proliferation which could contribute towards 
the development of cancer.  According to SEER Cancer Statistics Review (2013), 55–65% of 
women who inherit a mutation in the BRCA 1 gene and ~45% of women who inherit a 
mutation in the BRCA 2 gene could potentially develop breast cancer by the age of 70 years.  
 
1.3.2 Breast cancer treatment  
 
A combination of therapies (surgery, chemotherapy, radiation, targeted and hormone therapy) 
is available to treat cancer. However, negative effects of these treatments can adversely 
impact on the person’s ability to function and their quality of life.  
 
According to the American Cancer Society (2015), women have a 12% chance of developing 
invasive breast cancer and a 3% chance of dying from it. Breast cancer treatment entails 
surgical removal of the tumour that is followed by chemotherapy with or without radiation 
(Lim et al., 2011). For any stage of breast cancer, 79% of patients receives hormonal therapy. 
Miller et al. (2016) reported that 61% of women diagnosed with stage I or II breast cancer 
will undergo breast conserving surgery, while 36% will undergo a mastectomy. Among 
women diagnosed with stage III, 21 % undergo breast conserving surgery, whereas 72% 
undergo mastectomy. In women diagnosed with stage IV, 48% of patients receive 
chemotherapy only and/or radiation.  
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The primary treatment and prevention for breast cancer in women, frequently includes 
prophylactic mastectomy, which is used to remove one or both breasts, and lumpectomy, to 
remove the tumour (breast lump) and a surrounding margin of normal tissue. In early stage, 
long-term survival is the same as with mastectomy, when breast cancer surgery is followed 
by radiation to the breast, and suitable for localised cancers (Jatoi & Proschan, 2005; Litiere 
et al., 2012). Some patients require a mastectomy due to the characteristics of tumours (e.g. 
size, stage and number of tumours), and in some cases post-surgery radiation is inadvisable 
due to comorbid medical conditions (e.g. active connective tissue disease) or other 
obstructions. American women younger than 40, as well as patients with larger and/or more 
aggressive tumours are more likely to undergo a mastectomy (McGuire et al., 2009; 
Freedman et al., 2012). Worldwide, woman are increasingly choosing mastectomy above 
other treatments for a variety of reasons, such as refusal or unwillingness to undergo radiation 
therapy and dread of recurrence (McGuire et al., 2009).  
 
 
1.4 Radiation  
 
Based on how radiation affects matter, it can be classified as either being ionising or non-
ionising radiation. Non-ionising radiation is low-frequency radiation, including visible light, 
heat, radar, microwaves, and radio waves (Gherardini et al., 2014). This type of radiation 
comprises photons that do not have sufficient energy to break chemical bonds or ionise 
biological molecules (Kattou et al., 2014).  
 
The linear energy transfer (LET) is a physical quantity used to portray the quality of the 
radiation (Yukihara, & McKeever, 2011). The LET of a particular type of radiation is a 
measure of the average energy deposited along the track of a particle per unit length and is 
expressed in keV/µm (Hill, 1999). In essence, it reflects the mean ionisation density and 
represents a microdosimetric parameter. The LET depends on several parameters including 
the mass, charge and velocity/energy of the radiation (LaTorre Travis, 1989).  
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1.5 Ionising radiation (IR) 
 
Radiation that possesses adequate energy to emit one or more orbital electrons from the 
atoms or molecules by which it interacts, thus creating ions, is referred to as ionising 
radiation (IR) (Christensen et al., 2014). The ionisations and/or excitations are resultant from 
the course of radiation through cells initiating a series of events that can lead to biological 
damage.  
 
IR can be categorised into electromagnetic and particle radiation. Electromagnetic radiations 
include both X-rays and γ-rays (Hall & Giaccia, 2006). They have neither mass nor charge 
and as such they are considered either as waves or as discrete quanta of electromagnetic 
energy, called photons. Electromagnetic radiation is commonly used in experimental studies 
and in many clinical applications (Azeemi & Raza, 2005). Particle radiation comprises other 
types of radiation like protons, α-particles, negative π-mesons, heavy charged ions, and 
neutrons. As IR passes through material, it deposits sufficient energy to break molecular 
bonds and displace (or remove) electrons from atoms. This electron displacement generates 
two electrically charged particles, which may cause alterations in living cells of plants, 
animals, and people (Fig. 1.5).   
  
 
 
 
 
 
 
 
1.5.1 X-ray radiation 
 
Previous studies reported that contrast agents are taken up selectively by tumours leading to 
an enhanced therapeutic ratio by altering the lower energy photon interaction, thus delivering 
Figure 1.5: Types of IR. The penetrating ability of five 
major types of IR (http://www.nrc.gov/about-
nrc/radiation/health-effects/radiation-basics.html). 
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a highly localised dose to the tumour (Mello et al., 1983; Mesa et al., 1999). This is 
accomplished by loading the target volume with contrast agents and irradiating the target 
with kV X-rays where photoelectric effects are dominant. Contrast agents, materials of 
certain atomic numbers interact with radiation, with high-atomic-number (Z) includes, iodine 
(Z = 53), gadolinium (Z = 64) and gold (Z = 79) provide a high possibility for photon 
interaction by photoelectric effect (Mesa et al., 1999; Robar et al., 2002). In addition, the 
photoelectric effect produces high-LET and short range of photoelectric interaction products 
and Auger electrons to cause a highly localised dose enhancement in the tumour (Rahman et 
al., 2009). Auger electrons are weakly bound electrons with characteristic energies ejected 
from atoms in reaction to a descending transition by a different electron in the atom, resulting 
in the Auger effect. Auger electrons emit maximum energy of 0.5–25 KeV and travels short 
distance, typically 0.02–10 µm (Aktolun & Goldsmith, 2012). Therefore, they are only 
effective if the contrast agent or radiopharmaceutical is internalised in the cell, preferably 
close to the nucleus (Robertson et al., 2009). The biological effects of Auger emitters are 
highly dependent upon their cellular and subcellular distribution (Bingham et al., 2000). 
Auger electron emissions that occur within the cell nucleus generate effects similar to high-
LET radiations, such as α-particles.  
 
1.5.2 p(66)/Be neutron radiation  
 
Neutrons are uncharged particles and can be produced artificially when a charged particle, 
such as a deuteron or a proton, is accelerated to high energy and strikes a suitable target 
material (Hall & Giaccia, 2006; Lehnert, 2008). A major treatment of cancer is low LET 
photons, which damage cells either directly or indirectly through the production of free 
radicals causing DNA single or double-stranded breaks (DSBs) whereas high-LET radiation 
predominantly damages the DNA directly by breaking chemical bonds. X-ray photons 
interact with the orbital electrons of atoms of the absorbing matter (Fig. 1.6) while neutrons 
interact with the nuclei of atoms of the absorbing matter and set fast recoil protons, α-
particles and heavier nuclear fragments in motion (Hall & Giaccia, 2006; Aktolun & 
Goldsmith, 2012). 
 
Many tumours contain hypoxic regions (Yu et al., 2003; Yu et al., 2008) that render cells to 
be more resistant to low LET radiation than their normoxic counterparts due to decreased free 
 
 
 
 
14 
 
radical damage mediated by oxygen (Yu et al., 2003). The relative efficiency at deactivating 
cells by high LET compared to low LET beams are described as relative biological 
effectiveness (RBE) (Franken et al., 2011). Neutrons and other high-LET particles are less 
dependent on oxygen to exert an effect and therefore hypoxic cells are less resistant to 
neutron irradiation. There are various forms of DNA damage, but DSBs are regarded as the 
most lethal lesions induced by IR. It has been assumed that the increased RBE for cell death 
results from enhanced efficiency of high-LET radiation to induce these lesions. However, 
neutrons do not appear to induce more DSBs than X-rays for a given dose (Barendsen, 1994; 
Prise et al., 1994; Britten & Murray, 1997). According to Li et al. (2001), neutrons are 
difficult to target onto the tumour, and cause more DNA damage than photons resulting into 
adverse side effects to normal tissue. Therefore, it is not used often in clinical practises.  
 
 
 
 
 
 
 
 
 
 
 
1.6 Application of AuNPs in cancer 
 
1.6.1 Radiosensitisers 
 
The development of new AuNPs with biocompatible characteristics has stimulated and 
motivated research to pursue the application of AuNPs in combination with radiation therapy. 
In contrast to MV, kV X-rays have a limited penetration capacity. However, the use of 
AuNPs in combination with radiotherapy (RT) in numerous research studies with 
Figure 1.6: Examples of radiation damage to DNA resulting from both 
direct and indirect eﬀects. During the indirect effect, secondary electrons 
for instance, a water molecule (H2O) to produce a hydroxyl radical (OH
-
), 
which in turn produces damage to DNA (Hall & Giaccia, 2006).  
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orthovoltage X-rays have showed significant dose enhancement effects (Mousavie Anijdan et 
al., 2012). Orthovoltage X-rays are fairly low energy radiation sources (e. g. 150–200 kV) 
and at these energies, a considerably dose is deposited at the skin surface and 90% of the dose 
will occur at approximately 2 cm of depth in the tissue (Khan, 2003). The greatest challenge 
to treat underlying tumours is the limitation of radiation tolerance of the surrounding tissues; 
the skin dose becomes excessively large when adequate doses are to be delivered to 
underlying tumours (Khan, 2003; Medina et al., 2008). Disproportionate absorption of 
radiation in different types of tissues such as bone tissue opposed to soft tissue can result in 
damage to one type of tissue, in this example, bone damage. AuNPs are commonly used in 
radiation research applications, due to the high atomic number (Z) of gold (Z=79), which 
results in considerable differences in mass energy absorption properties in contrast to soft 
tissue (Kwatra et al. 2013). They have been proposed as excellent radiosensitisers by 
enhancing the vulnerability of the tumour tissue to radiation exposure without damaging 
healthy surrounding soft tissue (Kwatra et al., 2013). 
 
The AuNPs can selectively scatter and/or absorb X-ray radiations providing an increased 
interaction between photons of the radiation for improved targeting of cellular components 
within the tumour causing localised damage (Park et al., 2006; Carter et al., 2007). According 
to Kwatra et al. (2013), a combined treatment consisting of AuNPs and X-ray radiation 
results in reduction in the therapeutic radiation dose, thus limiting the damage to the healthy 
soft tissue. The utilisation of AuNP radiosensitisers is termed Nanoparticle Enhanced X-ray 
Therapy or NEXT (Praetorius & Mandal, 2007).  
 
1.6.2 AuNPs accumulation and clearance 
 
As mentioned previously, AuNPs are biologically compatible and have a great application in 
cancer detection and treatment (Huang et al., 2007; Tomar & Garg, 2013). Long circulating 
AuNPs are prone to accumulate in tumours by penetrating the leaking tumour vasculature. 
This process is known as the enhanced permeability and retention (EPR) effect (Maeda et al., 
2000; Maeda, 2010). After the nanoparticles leak out of these permeable blood vessels into 
the surrounding tissue, it is very difficult for the nanoparticles to be transported out again. 
Thus the presence of the nanoparticles allows doctors to visualise and locate the tumour by 
observing the site of nanoparticles. 
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It is of importance to note the distribution, biodistribution in organs, as well clearance from 
the body, of the AuNPs. Previous reports that the AuNPs accumulate in the liver and spleen 
suggest that they are recognised by phagocyte-rich reticuloendothelial system (RES) (Krpetic 
et al., 2009; Balasubramanian et al., 2010; Ema et al., 2010). Furthermore, nanoparticles that 
circulate for longer time periods, which are not small enough to be excreted via kidneys, are 
recognised and trapped by the RES (Kobayashi & Brechbiel, 2005). Sonavane et al. (2008) 
completed a size-dependent accumulation study (Fig. 1.7). In this study, AuNPs with 15, 50, 
100 and 200 nm diameter were administered intravenously in mice. The smaller size (15 nm) 
particles yielded the highest amounts in organs, including the liver, lung, spleen, kidney, 
brain, heart and stomach. Furthermore, an in vivo study conducted by Zhang et al. (2011) 
reported that BSA-conjugated AuNPs aggregated in 40–80 nm sized clusters, and 
accumulated mainly in the liver and spleen, whilst glutathione-conjugated AuNPs of 5–30 nm 
clustered size were cleared by the kidneys. Another study showed that AuNPs were released 
into the urine after 5 hours through filtration by the glomeruli (kidneys) (Hainfeld et al., 
2006).  
 
 
Figure 1.7: Size dependent accumulation. Schematic representation of size dependent accumulation and 
clearance of AuNPs bioconjugates in the organs of mice. (Zhang et al., 2011; Barchanski, 2016).  
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1.6.3 AuNPs sensitisation in cell line and animal models 
 
 
In an in vivo study performed by Hainfeld et al. (2004), 6 mice with subcutaneous breast 
cancer tumours were divided in three groups and treated with AuNPs to enhance radiotherapy 
toxicity for cancerous cells in mice. The first group was treated with AuNPs before 250 kVp 
X-ray radiation, the second group only received radiation, and the last group was only treated 
with AuNPs. Results showed that the group that received the combined treatment had the 
highest one-year survival (86%), in comparison to the radiation alone group (20%), and 
AuNPs alone group (0%) (Hainfeld et al., 2004). Therefore, the AuNPs enhanced the 
radiotherapeutic effects (Mesbahi, 2010). 
 
In an in vitro study conducted by Kong et al. (2008) thioglucose (Glu)-AuNPs were 
synthesised. The cell lines, MCF-7 (breast cancer cell line) and MCF-10A (non-cancerous 
breast cell line), were incubated with Glu-AuNPs and irradiated with 200 kVp X-rays. TEM 
micrographs showed that the uptake of Glu-AuNPs were significantly higher in MCF-7 cells. 
Furthermore, the results showed that the radiotherapy combined with AuNPs significantly 
induced cell death of MCF-7 cells, in comparison to MCF-10A cells and cells without AuNPs 
(Mesbahi, 2010). Targeting systems based on glucose receptors have been utilised to enhance 
the uptake of AuNPs into tumours allowing the distribution of high atomic mass atom with 
electron range for metal-enhanced radiation therapy, which can be implicated in further 
AuNPs studies (Hainfeld et al., 2006).   
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1.7 Overview of cell cycle 
 
1.7.1 The cell cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cell cycle consists of four phases, namely the synthesis phase (S), in which nuclear DNA 
is replicated and synthesised, and the mitotic phase (M), which is separated by two gap 
phases i.e. G1 and G2 (Fig. 1.8) (Imoto et al., 2011). Furthermore, after mitosis, a quiescent 
phase known as the G0 phase can also occur (Cooper, 1998; Coller, 2007; Daignan-Fornier & 
Sagot, 2011). In the G0 phase cells are at resting phase after mitosis, before the initiation of 
cell cycle (Fig. 1.8) (Cooper, 1998; Daignan-Fornier & Sagot, 2011). The main purpose of 
the cell cycle is to ensure that the DNA is replicated correctly in the S phase and that the 
division of two daughter cells are achieved during the M phase (Dalto, 1998; Blow & 
Tanaka, 2005).  
Figure 1.8: Diagram illustrating the four phases of the cell cycle. The cell cycle is the series of events 
that takes place in cells, which leads to cell division and replication. In eukaryotes, the cell cycle has two 
main phases: interphase and the mitotic phase. Interphase is the stage during which the cell prepares, 
grows and accumulates nutrients essential for mitosis and also replicates the DNA (Nurse, 1994).  In the 
mitotic phase, the cell divides into two separate cells known as 'daughter cells' and the final phase is 
cytokinesis, where the newly formed cells are fully divided (http://biology.tutorvista.com/cell/cell-
cycle.html).  
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Two key components of the cell cycle control system are cyclins and cyclin-dependent 
kinases (CDKs). CDKs are serine/threonine kinases that can phosphorylate multiple 
substrates (Dynlacht, 1997) leading to the regulation of cell cycle progression (Dubravka & 
Scott, 2000; Suryadinata, et al., 2010; Lim & Kaldis, 2013). The cell cycle cyclin-CDK 
activity is regulated by periodic synthesis of cyclins, proteolysis, phosphorylation of various 
protein substrates, inhibitory proteins, and tumour suppressor gene products, e.g. 
retinoblastoma protein (pRB) and p53. 
 
1.7.2 Cell cycle phases 
 
 
 
 
 
1.7.2.1 The G1 phase 
 
The G1 phase assess whether a cell is prepared to enter the S phase based on nutrients and the 
availability of growth factors (Saqcena, 2014). This is accomplished by means of the 
retinoblastoma (RB)/E2F pathway (Fig. 1.9). The pRB is a product of RB tumour suppressor 
gene. pRB plays an essential role in the regulation of the cell cycle through their control of 
the E2F family of transcription factors that regulate expression of a number of cell cycle 
components, such as cyclin E, cyclin A, Cdc25A and the transcription factor, E2F (Berride, 
2012).  In the G1 phase extracellular signals, such as growth factors, stimulate the production 
Figure 1.9:  Schematic representation of the RB/E2F pathway. Phosphorylation by cyclin D-CDK 4 and 
cyclin E-CDK 2, causes changes to the RB structure and releases E2F to activate cell division genes. 
Adapted from Freeman & Co (2004), Life: The Science of Biology, 7
th
 Edition. 
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of cyclin D, due to the increase in cyclin D, CDK 4/6 start to associate within (Fig. 1.9) 
(Cobrinik, 2005). The transition through the cell cycle is controlled by phosphorylation of 
specific targets on kinases (Dorée & Galas, 1994; Hochegger et al., 2008). Therefore, cyclin 
D-CDK 4/6 complex is activated by phosphorylation on theonine 172 (Thr
172
). The formation 
of the cyclin D-CDK 4/6 complex results in the confiscation of the CDK inhibitors (CDKI), 
p21
cip1
 and p27
kip1
 (after this called p27) and thus leading to the late G1 phase activation of 
cyclin E-CDK 2 (Sherr, 1994; Sherr & Roberts, 1999).  The activated cyclin D-CDK 4/6 
complex phosphorylates the tumour suppressor, RB, leading to the release of the transcription 
factor, E2F. The release of E2F can allow the cell by gene activation to progress through the 
restriction phase, into the S phase for DNA replication. 
 
1.7.2.2 The S phase 
 
During the S phase the genome is duplicated by DNA replication where each identical copy 
segregates into two daughter cells. Chromosome duplication is triggered by the activation of 
cyclin A-CDK 2, which activates proteins that unwind the DNA and initiate its replication at 
sites in the DNA called replication origins (Bertoli et al., 2013). The Cdc10-dependent 
transcript 1 (Cdt1) is required for formation of the pre-replicative complexes (preRC) and is 
an essential factor that binds to the recognition complex, and Cdc6 loads the 
minichromosome maintenance subunits 2-7 (MCM2-7) to initiate the complex for replication 
(Nishitani et al., 2001; Rialland et al., 2002; Soria & Gottifredi, 2010; Darzynkiewicz et al., 
2015).  
 
1.7.2.3 The G2/M phase 
 
The G2 phase and S phase of the cell cycle is driven by activated cyclin A-CDK 1 and cyclin 
B-CDK 1 complexes. During G2 phase the production of cyclin B is elevated and as cyclin B 
reaches threshold, the cell will enter mitosis (Lindqvist et al., 2009; Rhind & Russell, 2012). 
The activated cyclin B-CDK 1 triggers the assembly of the mitotic spindle leading to the 
segregation of the duplicated genome. The mitotic spindle is made up of microtubules (MTs) 
that can grow and shrink from their ends (Meunier & Vernos, 2012). These MTs can 
conjugate to chromosomes at specific sites known as kinetochores, which act as protein 
molecules that connect chromosomes to MTs and act as a signalling mechanism to coordinate 
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mitotic progression (Sacristan & Kops, 2015). A study conducted by Gayek & Ohi (2016), 
concluded that CDK 1 inhibition in G2 phase can impair the subsequent mitosis through an 
unknown mechanism that eventually stabilizes kinetochores-MTs (K-MTs). Mitosis (M 
phase) consist of the following phases, namely prophase, metaphase, telophase and anaphase. 
The loss of CDK 1 activity results in the activation of mitotic exit and completion of cell 
cycle (Niederhuber et al., 2013).  
 
1.7.3 Cell cycle checkpoints 
 
1.7.3.1 G1/S checkpoint 
  
DNA damage can be in the form of DNA single-strand breaks (SSBs) and/or double-strand 
breaks (DSBs) that leads to unstable chromosome structure and induce DNA damage 
response. The G1/S checkpoint is activated to avoid cells with damaged DNA occupied in the 
G1 phase from entering the S phase. G1/S checkpoint is more sensitive to a single DSB that 
can induce arrest, whilst a larger number is required to activate G2/M checkpoint (D' Adda di 
Fagagna, 2008).  The key molecular mechanisms of checkpoint pathways that are activated in 
response to DNA damage is the ataxia telangiectasia mutated (ATM) and Rad3-related 
(ATR) and subsequently downstream pathways causing the activation of p53 (Al-Ejeh et al., 
2010). DSBs activate ATM, whilst ATR is activated by either SSBs or DSBs, and both 
mechanisms trigger a series of phosphorylations (Medema & Macůrek, 2012). ATM 
phosphorylates the checkpoint kinase 2 (CHK2), while ATR phosphorylates the checkpoint 
kinase 1 (CHK1). Both CHK1 and CHK2 initiate the cell cycle arrest by phosphorylating cell 
division cycle 25A protein (CDC25A) that prevents the dephosphorylation of the cyclin D-
CDK 4/6 and cyclin E-CDK 2 (Mombach et al., 2014). This latter ceases phosphorylation 
events of RB and prevents the release of E2F transcription factors which allows the cell by 
gene activation to progress through the restriction point into the S phase. ATR, ATM, CHK1 
and CHK2 phosphorylate p53 that mediate the repairs at G1/S checkpoint arrest via the 
activation of p21 (Hyun & Jang, 2015). This CDKI inhibits Cyclin D-CDK 4/6 and Cyclin E-
CDK 2. Upon DNA repair, the complex Cyclin E-CDK 2 is activated and drives the cell from 
G1 to S phase (Mombach et al., 2014). 
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1.7.3.2 G2/M checkpoint 
 
The G2M checkpoint is an essential point that allows for a delay of cell cycle before 
segregation of chromosomes. Cyclin B-CDK 1 controls the entry into M phase (Tyner, 2009). 
Upon DNA damage, G2 arrest is initiated via phophorylation of Cdc25C by CHK1 and CHK2 
kinases (see section 1.7.3.1 G1/S checkpoint) preventing Cdc25C from activating CDK1 
complex (Charrier-Savournin et al., 2004). Therefore, cyclin B-CDK1 complex remains in its 
inactive form and preventing entrance into M phase.  
 
1.7.3.3 Mitotic checkpoint  
 
The segregation of sister chromatids at anaphase is controlled by the mitotic spindle. The 
mitotic spindle is made up of microtubules (MTs) that can grow and shrink from their ends 
(Meunier & Vernos, 2012). These MTs can conjugate to chromosomes at specific sites 
known as kinetochores, which act as protein molecules that connect chromosomes to MTs 
and as signalling mechanism to coordinate mitotic progression (Sacristan & Kops, 2015). As 
all kinetochores are attached and aligned at the metaphase plate, anaphase can proceed as 
allowed by the activation of E3 ubiquitin ligase known as the Anaphase-Promoting Complex 
or Cyclosome (APC/C) (Barnum & O’Connell, 2014). The APC activity is controlled by 
Cdc20, which is utilised until the metaphase-anaphase, and Cdh1, which aids in the APC-
mediated ubiquitination once cyclin degradation has started (McLean et al., 2011). When 
sister chromatid cohesion is released, spindle tension and the related motor proteins facilitate 
sister chromatids to move separately, forming identical daughter nuclei (McLean et al., 
2011). 
 
1.8 Cell cycle and radiation 
 
Cells that are exposed to IR will initiate a complex response that includes the arrest of cell 
cycle progression in G1 and G2, apoptosis and DNA repair (Hwang & Muschel, 1998). 
Irradiated cells will result in an increased effect on the levels and activity of p53. The main 
purpose of p53-dependent G1 arrest might be the removal of cells containing DNA damage, 
whilst G2 arrest following radiation has been shown to be important in protecting cells from 
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death (Hwang & Muschel, 1998; Teyssier et al., 1999).Thus, radiation will cause a G2 phase 
arrest mediated by p53. Moreover, radiation-induced G2 arrest was shown to require 
inhibitory phosphorylation of the cdc2 via an ATM-dependent pathway (Teyssier et al., 
1999). Therefore, the G2 checkpoint can be used in future studies as an essential approach for 
cancer therapy. 
 
1.9 Aims of the study 
 
The aim of this study was to determine possible toxicity caused by AuNPs and to establish 
whether scattered 6 MV X-rays, as well as p(66)/Be neutron radiation, will biologically and 
physically interact with AuNPs. Since AuNPs have been indicated as excellent 
radiosensitisers and may enhance the radiotherapy effect in cancerous cells, the 
radiosensitising enhancement effect of AuNPs was examined on the Chinese hamster ovary 
(CHO-K1) cell line, brain endothelial (BEnd5) cell line, breast cancer (MCF-7) and non-
cancerous breast (MCF-10A) cell line, by treating them with AuNPs. The treatment was 
followed by radiation of cells with 2 & 4 Gy X-rays and 1 & 2 Gy p(66)/Be neutrons, 
respectively. The objectives of this study were as follow:  
 Characterisation of 5 nm and 10 nm AuNPs. 
 To differentiate the reaction of non-malignant cells versus malignant cells treated with 
AuNPs, followed by radiation. 
 To study and quantify chromosomal aberrations in the cells that has been treated with 
AuNPs followed by ionising radiation exposure. 
 To evaluate AuNPs-treated cell proliferation.  
 To determine cell cycle progression of the cells treated with AuNPs followed by 
radiation exposure. 
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CHAPTER 2: 
MATERIALS AND METHODS 
 
 
2.1 Materials and Methods  
 
2.1.1 Reagents and cells 
 
All chemicals and solutions, including dimethyl sulfoxide (DMSO), tetrazolium bromide (3-
(4,5-dimethylazol-2-yl)-2,5-diphenyl-tetrazolium bromide, MTT), glutaraldehyde, osmium 
tetroxide, propylene, resin, uranyl acetate, propidium iodine (PI) and Acridine Orange (AO) 
were of analytical grade and purchased from Sigma-Aldrich (Johannesburg, South Africa).  
 
Gamma irradiated fetal bovine serum (FBS) was supplied via GIBCO (Cat# 16000044). 
Phosphate buffered saline (PBS) without Ca
+2
, Mg
+2
 or phenol red was purchased from 
WhiteSci (Cape Town, South Africa) and Trypsin (10X) was purchased from Sigma-Aldrich 
(Johannesburg, South Africa). Dulbecco’s Modified Eagle Medium (DMEM), Ham’s F-12 
Medium and RPMI 1640 Medium for tissue culture, and penicillin-streptomycin were 
obtained from Thermo Fisher Scientific (Johannesburg, South Africa). Epidermal growth 
factor (EGF), hydrocortisone and insulin were purchased from Sigma-Aldrich (Johannesburg, 
South Africa). The Chinese hamster ovary cells (CHO-K1) and Brain Endothelial cells 
(BEnd5) were a gift from Prof. J. P. Slabbert, NRF-iThemba LABS (Somerset West, Cape 
Town), whereas human breast adenocarcinoma (MCF-7) and non-tumourgenic human breast 
epithelia cells (MCF-10A) were purchased from American Type Culture Collection (ATCC), 
Maryland, United States of America.  
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2.1.1.1 Chinese Hamster Ovary (CHO-K1) cells 
 
This fast growing cell line is used as a standard model for experiments. The line of epithelial-
like CHO cells was initiated by T.T. Puck in 1957. Since then, CHO cells have become a 
widely used mammalian expression system in science (Gamper et al., 2005).  
 
2.1.1.2 Brain endothelial (BEnd5) cells 
 
BEnd5 cell line is a polyoma middle T-oncogen-immortalized mouse brain endothelioma cell 
line (Steiner et al., 2011). BEnd5 cell culture model could provide a useful in vitro model of 
the blood–brain barrier (BBB) for AuNPs (i.e. drug delivery) and visualising pathological 
states such as cell death.  
 
2.1.1.3 Michigan Cancer Foundation-7 (MCF-7) cells 
 
MCF-7 cell lines are an estrogen receptor (ER) positive cells which are derived from a patient 
with metastatic breast cancer. The MCF-7 cell line is the most studied human breast cancer 
cell line in the world, and results obtained from this cell line have had an essential impact 
upon breast cancer research and patient outcomes (Lee et al., 2015). MCF-7 cells are 
sensitive to estrogen, as well as sensitive to cytokeratin. Once grown in vitro, the cell line is 
capable of forming domes (upper half of a sphere) and the epithelial like cells grow in 
monolayers. (http://www.mcf7.com/).  
 
2.1.1.4 Michigan Cancer Foundation-10A (MCF-10A) cells 
 
The MCF-10A cell line is a non-malignant breast epithelial cell line and is positive for 
epithelial sialomucins, cytokeratins and milk fat globule antigen (Imbalzano et al., 2009). 
These cells are cultured in three-dimensional (3-D) reconstituted basement membrane culture 
and form domes in confluent cultures (Imbalzano et al., 2009; Qu et al., 2015). MCF-10A cell 
line has a stable, near-diploid karyotype (Yoon et al., 2009) and expresses normal p53 
(Debnath et al., 2003). MCF-7 and MCF-10A cells were used for comparison in this study. 
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2.1.2 Gold nanoparticles (AuNPs) 
 
The 5 nm and 10 nm AuNPs, in a citrate buffer, were purchased from Sigma-Aldrich 
(Johannesburg, South Africa). The AuNPs were filtered by the use of syringe filters (0.2 µm) 
(Cat# 431219) and stored in sterile 50 ml tubes to ensure that no contamination could occur.  
 
2.1.3 Sample collection and isolation of lymphocytes for γ-H2AX foci assay 
 
Peripheral blood samples were collected in sodium heparin blood collection tubes (Cat# 
368884 and BD Vactainer® PLUS) from healthy adult volunteers. Donors were non-smokers 
and had no history of radiotherapy treatment within the last ten years. CD3+ T cells were 
isolated from peripheral blood using the RosetteSep™ Human T Cell Enrichment Cocktail 
(Stemcell Technologies) by negative selection after density gradient centrifugation (Density: 
1.081 g/ml, RosetteSep™ Density Medium, Stemcell Technologies). Unwanted cells were 
targeted for removal with Tetrameric Antibody Complexes recognizing CD16, CD19, CD36, 
CD56, CD66b and glycophorin A on red blood cells (RBCs), resulting in a highly enriched 
population of CD3 T-lymphocytes (purity > 98%) (Vandevoorde et al. 2016).  
  
2.1.4 General cell culture procedures  
 
The CHO-K1 cells were cultured using RPMI 1640 medium supplemented with 10% FBS. 
MCF-7 cells were cultured using Dulbecco’s Modified Eagle’s medium F-12 (DMEM F-12) 
supplemented with 10% FBS, penicillin (100 µg/l) and streptomycin (100 µg/ml). MCF-10A 
and BEnd5 cells were all cultured using Dulbecco's Modified Eagle's medium F-12 (DMEM 
F-12) and Ham’s F-12 (50:50), supplemented with 5% Fetal Bovine Serum (FBS). 
Furthermore, the MCF-10A medium was supplemented with EGF (20 ng/ml final 
concentration), hydrocortisone (0.5 mg/ml final concentration), insulin (10 µg/ml final 
concentration), penicillin (100 µg/l) and streptomycin (100 µg/ml) (Debnath et al., 2003).   
The aforementioned cell lines were incubated at 37 °C, 5% CO2 air and humidified 
atmosphere. Tissue culture flasks, serological pipettes and filters were obtained from 
BIOCOM/Biotech. 
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Stock cultures of CHO-K1, MCF-7, MCF-10A and BEnd5 cells, taken from the -80°C 
freezer, were thawed quickly. The suspension was centrifuged at 900 rpm for 6 minutes, 
resulting in a pellet. The supernatant was aspirated and the pellet of cells was re-suspended in 
2 ml of culture media. Each 1 ml of cell suspension was added to 4 ml of culture media in a 
tissue culture flask, respective to the type of cell line. The cell viability and cell density was 
determined by staining the trypsinized cells with trypan blue in a ratio of 1 part cells in 
medium : 3 part dye : 6 part culture media and was loaded onto a haemocytometer and 
counted (Strober, 2001). When needed media was replaced respective to the specific cell line.  
 
When the culture flask reached ~75–80% confluence, the cells were trypsinised and some 
sub-cultured cells were placed in cryovials and stored at -80 °C to ensure a constant supply of 
low passage cells. The freeze media used to store the cells consisted of 70% culture media, 
20% FBS and 10% DMSO. 
 
2.1.5 Characterisation of AuNPs 
 
2.1.5.1 UV-visible (vis) absorption spectrophotometry 
 
The absorption of both AuNP solutions was measured via UV-vis spectrophotometry for the 
analysis of SPR to substantiate the presence of AuNPs, in addition to the estimated size and 
quantity. Samples were placed in cuvettes and the UV-vis spectra measurements were 
recorded within the 200–1000 nm wavelength range, using an Agilent 8453 
spectrophotometer (GenTech Scientific Inc.) and a software program known as UV-visible 
ChemStation.  
 
2.1.5.2 Zeta (Z) potential dynamic light scattering (DLS) and polydispersity index (PDI) 
 
The Z-potential is the main indicator of attractive or repulsive forces between nanoparticles. 
Therefore, this Z-potential parameter can be used to forecast the stability of the nanoparticles 
dispersion over a long-term period. A DLS measurement represents the hydrodynamic core 
size of nanoparticles in suspension. In addition, PDI measurements were used to determine 
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the size distribution width of the AuNPs. AuNPs samples were placed in capillary tubes for 
Z-potential and, in cuvettes for PDI measurements of AuNPs were determined using Malvern 
Instruments’ Zetasizer Nano ZS. The data was obtained in the phase analysis light scattering 
mode at 25 °C.  
 
2.1.5.3 Transmission electron microscopy (TEM) 
 
2.1.5.3.1 AuNPs within cells 
 
A TEM analysis was done to observe the presence, as well as the infiltration of AuNPs within 
cells. MCF-7 cells were seeded into 25 cm
2
 flasks, at 3x10
5
 cells per flask and the slow 
growing MCF-10A cells were seeded at 5x10
5
 cells per flask. Cells were allowed to attach 
overnight at 37 °C, 5% CO2 air and relative humidified atmosphere. Afterwards, each flask of 
cells was treated with 50 µg/ml of 10 nm AuNP solution for 4 hours. Subsequent to 
incubation, the media was removed and the cells were washed with PBS. To each of these 
flasks, 2.5% gluteraldehyde diluted in PBS (pH 7.4) was added for fixation of the cells. The 
cells were harvested through scraping and centrifuged at 1000 rpm for 3 minutes to obtain a 
pellet.  
 
Post-fixation, cells were washed thrice in 200 mM phosphate buffer for 5 minutes and stained 
with 1% osmium tetroxide diluted in 100 mM phosphate for 60 minutes. Afterwards, the cells 
were counter-stained with 1% uranyl acetate diluted in 100 mM phosphate. Both treated cell 
samples were washed with distilled water (dH2O) to remove phosphate ions, and thereafter 
dehydrated in ethanol (EtOH) (50, 70, 90 and 100%) for 5 minutes. Ethanol was then 
replaced with propylene oxide, and the cells were washed in this solution to remove plastic 
residues. The solution was removed and replaced with 50% propylene oxide and 50% resin 
solution and dried for 2 hours. The 50% solution was removed and replaced with pure resin 
and dried for extra 2 hours. 1 µm thick sections of each sample were made using a 
microtome, and deposited on a Formvar coated 200-300 mesh copper girds and analysed 
(TEM JEOL JEM-1011). The fixation steps were performed by a medical echnologist 
(Electron Microscopy) namely, Mrs Nolan Muller, from NHLS Tygerberg Hospital. The 
TEM images were also captured by Mrs Muller using Software Imaging System (SIS). 
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2.1.6 Experimental set-up for irradiation procedures  
 
All cell samples were irradiated as monolayers in 25 cm
2
 culture flasks and 9 cm
2
 petri 
dishes. The irradiation experiments were performed using a clinical linear accelerator 
(LINAC) operating at 6 MV peak photon energy mode and the p(66)/Be neutron beam with a 
mean neutron energy of 29 MeV at iThemba LABS (Somerset West, Cape Town, South 
Africa) (Fig 2.1 & 2.2). Gy can be defined as 1 joule (J) of energy deposited in 1 kilogram of 
mass.  
 
2.1.6.1 X-ray radiation 
 
X-ray radiation was conducted using a vertical beam (Philips SL 75-5 LINAC) directed 
downward through a 20x20 cm field of build-up material, referred to as a Shonka chamber, 
consisting of 20 mm polyethylene onto a 2 cm thick backscatter block of Perspex (Fig. 2.1).  
The LINAC was calibrated to use 6 MV X-rays, which was scattered by using a Shonka 
chamber to obtain lower energies X-rays to interact with the AuNPs. This procedure can be 
known as beam “softening”. The beam “softening” technique described by Berbeco (2012) 
was accomplished by using the Shonka chamber, mentioned above, to expect kV X-rays. The 
dose rate was 0.6 Gy/min for X-ray radiation. All the samples were placed at the machine’s 
isocenter and orthogonal to the central axis of the beam to ensure each sample was irradiated 
with the same dose. Following a 4 hour incubation period with AuNPs, cells were irradiated 
with a dose of 2 Gy or 4 Gy. According to Berbeco and co-workers (2012), AuNPs are of 
interest in radiotherapy for in vitro applications due to the high K-edge of Au (~81 keV), 
which can result in the emission of short-range photoelectrons upon radiation with low LET 
photons. 
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2.1.6.2 p(66)/Be neutron radiation 
 
The p(66)/Be neutron radiation set-up was in a 30x30 cm field of build-up material that 
consisted of 2x3 cm deep nylon tissue-equivalent material, onto three 3 cm thick backscatter 
blocks of Perspex (Fig. 2.2). All the samples were placed under the radiation field as 
mentioned in section 2.1.6.1. The dose rate was 0.5 Gy/min for p(66)/Be neutron radiation. 
Following AuNP incubation, cells were irradiated with doses of 1 Gy or 2 Gy p(66)/Be 
neutron radiation. The chosen X-ray and neutron radiation doses reflect similar relative 
biological effectiveness (RBE) to cause the same level of effect, given that the same amount 
of energy is absorbed within the cells/tissue. Therefore, 1 Gy p(66)/Be neutron radiation is 
approximately equivalent to 2 Gy X-radiation, in addition to reflecting the dosages received 
by patients in a clinical set-up (Franken et al., 2011).  
 
A B 
Figure 2.1: X-ray experimental set-up. (A) The red arrow shows the 20x20 cm Shonka chambers. The 
yellow arrow displays the distance from the gantry to the samples, which is 100 cm. (B) The red arrow 
shows the depth of the Shonka chamber (iThemba LABS, Somerset West, South Africa).  
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2.1.7 γ-H2AX foci assay 
 
The γ-H2AX foci assay is commonly used for the quantitative evaluation of induced DNA 
double-strand breaks (DSBs) formation in lymphocytes (Olive & Banath, 2004). In general, 
analysis of H2AX expression can be used to detect the genotoxic effect of different toxic 
substances (Podhorecka et al., 2010). The γ-H2AX foci assay was carried out in isolated 
human lymphocytes only, to establish radiation damage following a 4 hour treatment with 50 
µg/ml AuNPs. This assay in lymphocytes is seen as a quick informative tool of early DNA 
damage. After incubation with AuNPs of two different diameters (5 nm and 10 nm) and 
irradiation with x-rays or neutrons, isolated lymphocyte cells were centrifuged on poly-L-
lysine coated slides (VWR International) in a concentration of 6x10
5
 cells/ml. The slides 
were fixed in PBS containing 3% paraformaldehyde (PFA) (Life Technologies) for 20 
minutes and stored overnight in PBS (4 °C) containing 0.5% PFA. The next day, slides were 
washed with PBS for 10 minutes and treated with 0.2% (v/v) Triton X-100 solution (Life 
Technologies) in PBS for 10 minutes. Thereafter, cells were blocked by washing them three 
times for 10 minutes in PBS containing 1% Bovine Serum Albumin (BSA) obtained from 
Sigma-Aldrich (Johannesburg, South Africa). Immunohistochemistry staining was performed 
using a monoclonal primary antibody (Ab) against γ-H2AX (1:500, Mouse mAb, Life 
Technologies). Slides were incubated with the primary Ab for 1 hour at room temperature. 
A B 
Figure 2.2: p(66)/Be neutron radiation set up. (A) The red arrow shows the 30x30 cm radiation field. (B) 
The yellow arrow shows the samples in petri dishes and the red arrow shows three Perspex blocks, each block 
is 3 cm thick (iThemba LABS, Somerset West, South Africa). 
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After washing the cells three times in PBS containing 1% BSA the slides were incubated for 
1 hour at room temperature with Tetramethyl Rhodamine Isothiocyanate (TRITC) rabbit-anti-
mouse Ab (1:1000, Life Technologies) as secondary Ab. Afterwards, the slides were rinsed 
three times in PBS and mounted in Fluoromount purchased from Sigma-Aldrich 
(Johannesburg, South Africa) containing 2% 4’,6-Diamidino-2-Phenylindole (DAPI) (Life 
Technologies).  
 
Slides were stored in a cool, dark place before image capturing to allow the mounting 
medium to dry and to avoid fading of the fluorescent signal. Slides were scanned by a 
Metafer 4 System (Metasystems) at iThemba LABS (Fig. 2.3). Metafer system is a special 
platform to automatically scan samples. Images were obtained automatically by using 
MetaCyte software (40x Magnification). In each experiment, at least 1000 cells were scored 
over two slides in randomly selected fields of view.  
 
 
Figure 2.3: The Metafer 4 System set-up. (A) The complete Metafer 4 System (Metasystems) equipped with a 
40x objective. The white arrow shows the stage of the inverted fluorescence microscope (Zeiss) that can contain 
8 slides. (B) Detailed image to show precisely the location of the cell containing DNA DSBs, on the slide – 
indicated by the white arrow (iThemba LABS, Somerset West, South Africa). 
 
2.1.8 Cytokinesis-block Micronucleus (CBMN) assay 
 
The CBMN assay is a cytogenetic test for the measurement of chromosome breakage and loss 
in nucleated cells. The micronuclei (MNi) observed in binucleated cells (BNCs) are minute 
extracellular bodies, separated from the main nucleus, that consist of acentric fragments (Fig. 
 
 
 
 
33 
 
2.5) (Fenech et al., 2003). As a result, MNi present a consistent index of chromosome 
damage due to radiation damage at the G0 phase of the cell cycle (Vral et al., 2011).  
 
Exponentially growing CHO-K1, MCF-7, MCF-10A and BEnd5 cells were seeded on cover 
slips at 4x10
3
 per 9 cm
2
 petri dish and allowed to attach overnight. All the above mentioned 
cells were treated with 50 µg/ml with both types of AuNP and subsequently irradiated with 
X-ray and p(66)/Be neutron radiation respectively, after which the CBMN assay was 
performed. Controls consisted of a negative control (i.e. no AuNPs and no radiation), AuNP 
controls (i.e. no radiation) and radiation controls (i.e. no AuNPs) following 4 hours 
incubation. Irradiation was done by using the beam “softening” technique (Berbeco et al., 
2012). The fraction of photons in a clinical megavoltage (MV) beam depends on the depth of 
material. Beam “softening” will occur at deeper measurement points as the contribution of 
low-energy scattered photons become more significant relative to the attenuated primary 
beam (Berbeco et al., 2012). Therefore, this application involves the use of 6 MV photon 
beam over a fairly large distance to enhance the production of low-energy scattered photons, 
with AuNPs penetrating into the cells, leading to damage enhancement as a function of 
amplified depth. Enhanced interaction indices between the AuNPs and scattered 6 MV 2 Gy 
X-rays were observed in the CHO-K1 and MCF-7 cells only. Therefore, only these two cell 
lines were further used in the study to validate and further investigate the interaction between 
the AuNPs and radiation. Further studies included a change in the radiation dose from 2 to 4 
Gy X-rays and a decrease in the AuNP concentration from 50 μg/ml to 2.5 μg/ml. These 
AuNP treated cells were also irradiated with 1 Gy and 2 Gy neutrons (separate experiments) 
to establish whether the interaction between AuNPs and scattered 6 MV 2 Gy X-rays would 
still exist. Irradiation experiments were performed as described in sections 2.1.6, 2.1.6.1 and 
2.1.6.2. The CBMN assay was performed by following the same protocol provided by 
iThemba LABS Somerset West. After radiation treatment, media with AuNPs was removed 
and fresh culture media was added to each cell line. 2.25 µg/ml cytochalasin B was added to 
each experimental sample, to inhibit cytoplasmic division to enable the observation of MNi 
after anaphase division, and incubated for 24 hours. Thereafter, the media was removed and 
the cells were washed with PBS (pH 7.4). This was followed by the addition of 1 ml cold 
methanol/acetic acid (3:1) for a 5 minute fixation. The fixative was removed and the cells 
were allowed to air-dry for 15 minutes. A 0.1% aqueous solution of acridine orange (AO) 
was prepared for staining, in which a stock solution of 0.24 mM of the stain was diluted in 
Gurr buffer (pH 6.8) (Gibco Cat# 10582-013 and 1 Gurr buffer tablet supplied from 
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ThermoFisher Scientific was dissolved in 1 L of DH2O). The fixed cells on the cover slip 
were stained with AO for 1 minute and rinsed for 1 minute in Gurr buffer. The stained cover 
slips were placed on the centre of the labelled microscope slides, with the excess buffer being 
blotted, and the slides were sealed with Fixogum Rubber Cement (SMM Instruments, Cat# 
LK-071A).  
 
Following the guidelines indicated by Fenech (2000), Fenech et al. (2003) and Vandersickel 
et al. (2010), scoring of 500 BNCs per slide was done manually using an inverted 
fluorescence microscope (Zeiss), and the FITC filter. MNi are counted within BNCs to 
ensure that any possible damage enhancement that has occurred will be observed as acentric 
fragments within the BNCs. The “scoring” of MNi within the BNCs was completed by 
counting the number of MNi within the BNCs and binning them as 0, 1, 2, 3, 4, etc., to 
generate a ratio of total MNi within the entire population of BNCs per slide.  
 
 
Figure 2.4: Different types of BNCs in the CBMN assay. (A) Ideal BNC, (B) a BNC with touching 
nuclei, (C) BNC with thin nucleoplasmic bridge between nuclei and (D) BNC with rather thick 
nucleoplasmic bridge (Fenech et al., 2003).  
Figure 2.5: The characteristic appearance and relative size of MNi in BNCs. (A) BNC with two MNi 
containing viable MNi varying un sizes between 1/3 to 1/9 of the main nuclei. (B) BNC with three MNi 
touching, but not overlapping the main nuclei. (C) A BNC with nucleoplasmic bridge between main nuclei 
and two MNi. (D) A BNC with six MNi varying in sizes (Fenech et al., 2003). 
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2.1.9 Cell viability assay 
 
Both CHO-K1 and BEnd5 cells were plated sub-confluent at 1x10
2
 cells per well due to their 
fast growth nature. MCF-7 cells were plated sub-confluent at 7.5x10
3
 cells per well and 
MCF-10A cells were plated at 10x10
3
 cells per well. In the time and dose study, 
exponentially growing CHO-K1, MCF-7, MCF-10A and BEnd5 cells were plated into flat-
bottomed 96-well tissue culture plates and allowed to attach overnight. Thereafter, cells were 
treated with different concentrations of the two types of AuNPs (2.5, 5, 10 and 50 µg/ml) for 
different times (4 hours non-irradiated, 4 hours irradiated with 4 Gy scattered 6 MV X-rays, 
and 24 hours non-irradiated) in triplicate. The cells were irradiated with 4 Gy X-rays to 
obtain the maximum effect on cellular proliferation after 4 hours. The average of all the 
experiments is shown as the cell-viability percentage in comparison with the control, which is 
the untreated cells and considered as 100%. The controls consisted of non-irradiated cells 
without AuNPs and irradiated cells without AuNPs. At the end of each treatment period, the 
toxicity level was measured by adding MTT (5 mg/ml), diluted in PBS (pH 7.4), to each well. 
The plates were covered with foil, due to light sensitivity, and incubated at 37 °C, 5% CO2 air 
and relative humidified atmosphere for 4 hours. Following incubation, the MTT solution was 
removed and the formazan solvent DMSO, was added. The plate was covered again with foil 
and placed on a rocker for 15 minutes. The MTT assay was used to determine the AuNP 
effect on the cell viability by measurement of enzymatic reduction of yellow tetrazolium to a 
purple formazan by cellular mitochondria (Fig. 2.6) and detected by a whole plate read using 
PhotoRead Software via Apollo LB 913 (Berthold technologies) UV-vis spectrophotometer at 
570 nm. The MTT assay followed the procedure as described by Riss et al. (2013) in the 
Assay Guidence Manual.  
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2.1.10 Cell cycle analysis  
 
Flow cytometry measures numerous types of individual particles flowing in single file in a 
stream of fluid (Fig. 2.7) (Brown and Wittwer, 2002). According to Brown and Wittwer 
(2002) physical properties like size, represents forward angle light scatter) and internal 
complexity which corresponds to right-angle scatter) and can determine cell populations. 
Flow cytometry can be used to analyse the progression of the cell cycle as the light scatters of 
the population of cells and excites the fluorescent probe to emit a certain colour (Krishan, 
1975). This is quantified by a particular software program. In this study, propidium iodine 
(PI) was used to bind to double stranded (ds) DNA. The stained DNA will in this way emit 
fluorescence from stained cells as it passes through the laser beam. Flow cytometric analysis 
provides quantitative data and the ability to measure large numbers of cells swiftly.  
 
Each cell line was seeded at 5x10
4
 cells per 25 cm
2
 flask and was allowed to attach overnight 
under the specific conditions described in section 2.1.4. The following day, it was exposed to 
50 µg/ml of either 5 nm or 10 nm AuNPs. Cells were harvested and then centrifuged (Jouan 
B4 Centrifuge) for 6 minutes at 900 rpm (25 C) for pellet formation and washed with PBS 
(pH 7.4). Permeabilization of the cell membrane was achieved by fixing the cells in 3 ml of 
ice cold 99.5% EtOH. The fixed cell suspensions were stored at -20 °C overnight. 
Subsequently, the EtOH was removed by centrifugation at 1400 rpm for 5 minutes and the 
cells were washed with PBS (pH 7.4) twice. The supernatant was removed without disturbing 
the pellet and the sediment was resuspended in  1 ml of the hypotonic DNA staining buffer 
Figure 2.6: Example of MTT assay. 96 well plate, in which 
the MTT solution was removed and the formazan solvent 
DMSO was added, resulting in a purple colour. 
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(20 µg/ml) and stored at 4°C protected from the light for 30 minutes, prior to utilization of  
the BD ACCURI-C6 flow cytometer. The flow cytometer used a BD FITC BrdU flow kit 
(Cat# 559619) and was equipped with a 488-nm laser, which excites FITC and 7-AAD. After 
data is collected, the BD ACCURI-C6 software Zoom function allows visualisation of data to 
set up specific gates and regions. For each cell sample 10 000 events were collected and 
aggregated cells were gated out. The PI staining method was provide by Prof. Slabbert from 
iThemba LABS, Somerset West. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2.7: Mechanisms of flow cytometry. There are four general components of a 
flow cytometer: fluidics, optics, detectors and electronics. Cells in suspension flow in 
single-file through an illuminated volume, where they scatter light and emit fluorescence 
that is collected, filter and converted to digital numbers that are stored on a computer 
(Brown et al., 2002). 
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2.1.11 Statistical analyses 
 
2.1.11.1 γ-H2AX foci assay 
 
Automated scoring of ~1000 lymphocytes was completed via a Metafer 4 System. Statistical 
analysis was completed via MedCalc program (Version 14.8.1). Multiple comparison graphs 
(Box-and-Whisker plots) were used to visualise and quantify the influence of the AuNP types 
and radiation on each sample in an experimental group. The central box in the diagram (Box-
and-Whisker) represents the lower and upper quartiles (25 to 75 percentile), therefore the box 
contains the middle 50% of the values. The middle line in the box represents the median. 
From each end of the box a line is drawn to the most remote point that is not an outlier. The 
Kruskal-Wallis test was performed to identify sample means that are significantly different 
from each other and results were considered statistically significant if p < 0.05. 
 
2.1.11.2 Cytokinesis-block Micronucleus (CBMN) assay 
 
Manual scoring of MNi from 500 BNCs per slide was completed as described above. The 
mean cumulative frequency for each experimental group (Control, X-ray and p(66)/Be 
neutron radiation) for both types of AuNPs was then calculated, and represented in bar 
graphs. 
 
For the determination of cellular kinetics, 400 BNCs were counted per conditions and 
expressed as a percentage (%) of the total number of cells viewed. The % of cells whose 
nuclei were able to divide after treatment (cellular kinetics) for each experimental group 
(Control, X-ray and p(66)/Be neutron radiation) for both types of AuNPs was then calculated, 
and represented in bar graphs. 
 
2.1.11.3 Cell viability assay 
 
MedCalc statistical software version 14.8.1 was used to analyse data. One-way ANOVA 
(Kruskal-Wallis test) was used to determine the significant difference between the control 
means and experimental groups. Statistical analysis was completed via MedCalc program 
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(Version 14.8.1). Multiple comparison graphs (Box-and-Whisker plots) with bars were used 
to visualise and quantify the influence of the AuNPs types and radiation on each sample in an 
experimental group. Kruskal-Wallis tests were performed for all independent comparisons 
and results were considered statistically significant if p < 0.05. 
 
2.1.11.4 Cell cycle analysis 
 
Flow cytometry results obtained was determined by using BD ACCURI-C6 software Zoom.  
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CHAPTER 3: 
RESULTS  
 
 
3.1 Characterisation of AuNPs 
 
3.1.1 UV-visible (vis) absorption spectrophotometry 
 
The absorption of both AuNP solutions was measured via UV-vis spectrometry for the 
analysis of surface plasmon resonance (SPR) to confirm the presence of AuNPs, as well as 
approximate size and quantity.  
 
 
Figure 3.1: The absorption of each AuNP solution. UV-vis spectrum of both types of AuNPs was obtained 
using the Agilent 8453. Absorbance profiles were measured between 525–580 nm, with an SPR of 525 nm 
occurring for 5 nm AuNPs (A) and 10 nm AuNPs (B). The red vertical line represents the λmax at 525 nm and 
indicates the presence of AuNPs. 
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3.1.2 Zeta (Z) potential, dynamic light scattering (DLS) and polydispersity index (PDI)  
 
Z-potential is an indication of repulsive and attractive forces between nanoparticles and can 
predict the long-term stability of nanoparticles in the solution. PDI values represent the size 
distribution width of nanoparticles. Furthermore, DLS measurements were used to determine 
the hydrodynamic size of citrate-coated AuNPs.  
 
Figure 3.2.1: Zeta (Z) potential measurements of 5 nm and 10 nm AuNPs.  The Z-potential of 5 (A) and 10 
(B) nm AuNPs was -24.5 mV and -23.2 mV, respectively. The negative Z-potential values present the necessary 
repulsive forces for the particles to remain stable in the solution. Nanoparticles with Z-potential < -30 mV are 
regarded as strongly anionic, whereas nanoparticles with a Z-potential > +30 mV are regarded as strongly 
cationic. Data was obtained in phase analysis light scattering mode at 25 °C and pH 7.4 (Addendum: Fig. 5.1). 
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Figure 3.2.2: PDI represents the size distribution width, whereas DLS (Z-average) displays the 
hydrodynamic core size of both 5 and 10 nm AuNPs. A PDI value of 0.1–0.25 suggests that the nanoparticles 
have a uniform size distribution, whilst a PDI > 0.5 indicates a very broad distribution. Results conducted shows 
that both sizes of AuNPs have a uniformity size width distribution. DLS measurements (Z-average) show that 
the 5 nm AuNPs are 38.12 nm in diameter (A), whilst 10 nm AuNPs are 48.50 nm in diameter (B). These larger 
sizes in diameter may be due to the agglomeration state of nanoparticles as a function of time or suspending 
solution. Data was obtained in phase analysis light scattering mode at 25 °C and pH 7.4 (Addendum: Fig. 5.2). 
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3.1.3 Transmission electron microscopy (TEM) 
 
TEM was used to determine the uptake and location of the AuNPs in two cell lines namely 
MCF-7 and MCF-10A cells. 
 
3.1.3.1 AuNPs within MCF-7 & MCF-10A cells 
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Figure 3.3: TEM micrographs of MCF-7 cells (A–F) and MCF-10A cells (G–L) tested with 50 µg/ml of 10 
nm AuNPs. A large number of vesicles transporting AuNPs were observed in the MCF-7 cells. After the 4 hour 
incubation period, some AuNPs were observed in the vicinity of the nucleus. Red arrows indicate the nuclear 
membrane of the cell, blue arrows indicate possible autophagosomes or transport vesicles, yellow arrows 
represents the 10 nm AuNPs, pink arrows shows swollen mitochondria and the green arrows indicate possible 
lysosomal bodies. The swollen mitochondria could possibly be due to AuNP induced cytotoxic stress. AuNPs 
are taken up by endocytosis which is clearly indicated by the orange arrows (J), (E) and (F), which indicates the 
distance from the AuNPs to the nuclear membrane; 0.12 µm, 0.15 µm and 0.49 µm, respectively. The TEM 
measurement of the AuNPs via SIS confirmed that it is 10 nm in diameter (G). AuNPs were observed in the 
nucleus (A and B), within the cells and near the nuclear membranes of the cells. 
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3.2 DNA double-strand breaks 
 
The γ-H2AX foci assay has been shown to be a reliable and sensitive indicator of radiation-
induced DNA DSBs and has potential as a biodosimetry tool from hours to approximately 3 
days post exposure. Radiation and AuNPs-induced DNA DSBs were assessed by automated 
microscopic scoring of γ-H2AX foci (Fig. 3.4), after low dose X-ray radiation exposure. The 
number of foci per cell increased for cells treated with AuNPs and X-ray and p(66)/Be 
neutron irradiations, as compared to the control (Fig. 3.5). The combined treatment (AuNPs 
and IR) obtained higher endogenous foci in lymphocytes, in comparison to lymphocytes that 
were only treated with AuNPs alone (Fig. 3.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Visualisation of γ-H2AX foci. Examples of isolated human lymphocytes after the γ-H2AX foci 
assay, wherein (A–C) illustrates non-radiated control samples, (D–F) non-radiated lymphocytes incubated with 
5 nm AuNPs, (G–I) lymphocytes irradiated with 5 nm AuNPs, (J–L) non-radiated lymphocytes incubated with 
10 nm AuNPs and (M–O) lymphocytes irradiated with 10 nm AuNPs. The blue area represents the isolated 
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human lymphocyte nuclei and the green ‘dots’ show the foci, which represent the amount of DNA DSBs in the 
cell. All samples were treated with either 50 µg/ml of AuNPs or with AuNPs and 1 Gy X-rays.  
 
Figure 3.5: Box-and-Whisker plot representing γ-H2AX foci in isolated lymphocytes. Box-and-Whisker 
plots represents the quantification of effects of isolated human lymphocytes incubated with culture media 
containing 50 µg/ml of AuNPs for 4 hours followed by 1 Gy X-rays or 1 Gy p(66)/Be neutron radiation, 
respectively. Significant increases (p < 0.000001) in foci are observed in the overall cell count compared to the 
control. * represents only two data points obtained for the p(66)/Be neutron radiation experiment (Addendum: 
Table 5.3). 
 
3.3 Cytogenetic damage 
 
Fig. 3.6–3.17 show fluorescent images of MNi with binucleated cells (BNCs) in different cell 
lines after exposure to different concentrations of AuNPs and either 2 or 4 Gy X-rays, as well 
as 1 or 2 Gy p(66)/Be neutrons. Quantification of cellular kinetics after treatment and MNi 
induction in these experiments are displayed in Fig 3.18–3.29. 
 
3.3.1 Visualisation of MNi with binucleated cells (BNCs)  
 
3.3.1.1 Cells incubated for 4 hours with 50 µg/ml of AuNPs and 2 Gy X-ray radiation 
 
Fig. 3.6–3.9 shows acridine orange (AO) stained BNCs of CHO-K1, BEnd5, MCF-7 and 
MCF-10A cells exposed to 2 Gy X-rays. Each figure shows: (A) non-radiated control, (B) 
irradiated control, (C) non-radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 50 
* 
* 
* 
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µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells with 50 µg/ml of 10 nm AuNPs and (F) 
cells with 50 µg/ml irradiated 10 nm AuNPs. All cell types (malignant and non-malignant) 
display a similar morphology once they have undergone the CBMN assay.  
 
Figure 3.6: CHO-K1 cells after CBMN assay, wherein (A) illustrates a BNC, (B) two BNC, each with one 
micronuclei (MNi), (C) a characteristic apoptotic cell indicated via a blue arrow, (D) a BNC with one MNi, (E) 
a BNC with three MNi and (F) a BNC with four MNi. White arrows indicate MNi within BNCs.  
 
Figure 3.7: BEnd5 cells after CBMN assay, wherein (A) illustrates a two BNCs, (B) two mononucleated cells, 
and a BNC with one MNi, (C) and (D) a BNC with one MNi, (E) a mononucleated cell, and a BNC with three 
MNi and (F) two BNC, one with two MNi. White arrows indicate MNi within BNCs. 
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Figure 3.8: MCF-7 cells after CBMN assay, wherein (A) illustrates a BNC, (B) a BNC with three MNi, (C) two 
BNC with four and five MNi, respectively, (D) a BNC with an anaphase bridge between the cells, (E) a BNC 
and a possible apoptotic cell and (F) a BNC with multiple MNi. White arrows indicate MNi within BNCs, blue 
arrow indicates a characteristic apoptotic cell and pink arrows indicate an anaphase bridge. 
 
Figure 3.9: MCF-10A cells after CBMN assay, wherein (A) illustrates two BNCs, (B) a BNC with two MNi, 
(C) two BNCs, (D) a BNC, (E) a mononucleated cell, and a BNC with three MNi and (F) a BNC with one MNi. 
White arrows indicate MNi within BNCs and the pink arrow indicate an anaphase bridge. 
 
Based on results showed in Fig. 3.18–3.22 an interaction between the AuNPs and 6 MV 2 Gy 
X-rays was only noted in two cell lines, namely CHO-K1 and MCF-7. Only CHO-K1 and 
MCF-7 cells lines were used for further investigation in the CBMN assay, since the 
interaction indices were greater than Unity (Unity = 1) (Fig. 3.18 & 3.20).
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3.3.1.2 Cells incubated for 4 hours with 50 µg/ml of AuNPs and 4 Gy X-ray radiation 
 
Fig. 3.10 and 3.11 shows AO stained BNCs of CHO-K1 and MCF-7 cells after an increased 
dose of radiation, namely 4 Gy. (A) non-radiated control, (B) irradiated control, (C) non-
radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 50 µg/ml irradiated 5 nm AuNPs, 
(E) non-radiated cells with 50 µg/ml of 10 nm AuNPs and (F) cells with 50 µg/ml irradiated 
10 nm AuNPs. No change in the morphology of both the CHO-K1 and MCF-7 cells could be 
observed after the CBMN assay.  
 
 
Figure 3.10: CHO-K1 cells after CBMN assay, wherein (A) illustrates a BNC, (B) a BNC with multiple MNi, 
(C) a BNC with two MNi, (D) a BNC, and (E) and (F) a BNC with multiple MNi. White arrows indicate MNi 
within BNCs, the blue arrow illustrates a characteristic apoptotic cell and yellow arrow indicates cell blebbing.  
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Figure 3.11: MCF-7 cells after CBMN assay, wherein (A) illustrates a BNC, (B) four BNCs with multiple MNi, 
(C) a BNC with two MNi, (D) a BNC with four MNi, (E) a BNC with two MNi, and (F) two distinctive 
apoptotic cells. White arrows indicate MNi within BNCs, the blue arrow illustrates a distinctive apoptotic cell 
and pink arrow indicates an anaphase bridge.  
 
Considering all the cell types (Fig. 3.6 – 3.11), a low radiation dose yielded less MNi and a 
high radiation dose (4 Gy) yielded more MNi. A decrease in the interaction indices between 
AuNPs and 4 Gy X-rays is observed in CHO-K1 and MCF-7 cells (Fig 3.22 & 3.23). Based 
on the results from figures 3.19 and 3.21, the interaction indices between the AuNPs and 2 
Gy X-rays in BEnd5 (0.92–1.06) and MCF-10A (0.87–0.97) is slightly higher, in comparison 
to the cells exposed to higher dose of radiation (4 Gy) (i.e. 0.74–1.04). Thus, the higher the 
radiation dose (e.g. 4 Gy), the smaller interaction indices between AuNPs and radiation.   
 
3.3.1.3 Cells incubated for 4 hours with 2.5 µg/ml of AuNPs and 2 Gy X-ray radiation 
 
Fig. 3.12 and 3.13 shows AO stained BNCs of CHO-K1 and MCF-7 cells exposed to a low 
concentration of AuNPs. Each figure shows: (A) non-radiated control, (B) irradiated control, 
(C) non-radiated cells with 2.5 µg/ml of 5 nm AuNPs, (D) cells with 2.5 µg/ml irradiated 5 
nm AuNPs, (E) non-radiated cells with 2.5 µg/ml of 10 nm AuNPs and (F) cells with 2.5 
µg/ml irradiated 10 nm AuNPs. Both cell lines (non-malignant and malignant) display a 
similar morphology 
 
 
 
 
51 
 
 
Figure 3.12: CHO-K1 cells after CBMN assay, wherein (A) illustrates two BNCs, (B) two BNCs; one with one 
MNi, (C) two BNC, and a cell in prometaphase, (D) and (E) four BNC, and (F) a BNC with one MNi, and a cell 
in early anaphase. White arrows indicate MNi within BNCs, the blue arrows indicate distinctive apoptotic cells, 
orange arrows indicate metaphases, and the purple arrow shows that the cells are pyktonic.   
 
Figure 3.13: MCF-7 cells after CBMN assay, wherein (A) illustrates two BNCs, (B) a BNC with two MNi, (C) 
two BNCs, (D) two BNCs; one with one MNi, (E) six BNCs, (F) three BNCs; one with two MNi. White arrows 
indicate MNi within BNCs and the pink arrow points to an anaphase bridge.   
 
The lower concentration (2.5 µg/ml) of AuNPs yielded less MNi in both CHO-K1 and MCF-
7 BNCs, signifying a smaller amount of damage to the cells (Fig 3.24 B & 3.25 B). The non-
irradiated or irradiated AuNPs (2.5 µg/ml) affected 20–30% of the CHO-K1 cellular kinetics 
(Fig. 3.24 A), whereas the 50 µg/ml of AuNPs affected 60–70% (Fig. 3.18).
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3.3.1.4 Cells incubated for 4 hours with 50 µg/ml of AuNPs and 1 Gy p(66)/Be neutron 
radiation 
 
Fig. 3.14 and 3.15 shows AO stained BNCs of CHO-K1 and MCF-7 cells.  (A) non-radiated 
control, (B) irradiated control, (C) non-radiated cells with 50 µg/ml of 5 nm AuNPs, (D) cells 
with 50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells with 50 µg/ml of 10 nm AuNPs 
and (F) cells with 50 µg/ml irradiated 10 nm AuNPs. Both CHO-K1 and MCF-7 cells (non-
malignant and malignant) display a similar morphology once they have undergone the 
CBMN assay.  
 
 
Figure 3.14 CHO-K1 cells after CBMN assay, wherein (A) illustrates three BNCs, (B) three BNCs; one with 
three MNi, (C) and (D) a BNC with one MNi, and (E) and (F) a BNC with an anaphase bridge between the 
cells.  White arrows indicate MNi within BNCs, a yellow arrow shows blebbing of the cell and pink arrow 
shows a distinctive anaphase bridge. 
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Figure 3.15: MCF-7 cells after CBMN assay, wherein (A) illustrates two BNCs, (B) a BNC with different sizes 
of MNi, (C) BNCs with one MNi and one without MNi, (D) two BNCs, both containing two MNi, (E) a BNC 
with four MNi, and (F) three BNCs with various sizes and quantities of MNi. White arrows indicate MNi within 
BNCs and the pink arrow shows a distinctive anaphase bridge. 
 
The irradiated samples showed an increased number of MNi within the CHO-K1 and MCF-7 
BNCs in comparison to the non-irradiated samples (Fig. 3.26 B & 3.27 B).  
 
 
3.3.1.5 Cells incubated for 4 hours with 50 µg/ml of AuNPs and 2 Gy p(66)/Be neutron 
radiation 
 
Fig. 3.16 and 3.17 shows AO stained BNCs of CHO-K1 and MCF-7 cells. Each figure shows 
the following micrographs: (A) non-radiated control, (B) irradiated control, (C) non-radiated 
cells with 50 µg/ml of 5 nm AuNPs, (D) cells with 50 µg/ml irradiated 5 nm AuNPs, (E) non-
radiated cells with 50 µg/ml of 10 nm AuNPs and (F) cells with 50 µg/ml irradiated 10 nm 
AuNPs.  
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Figure 3.16: CHO-K1 cells after CBMN assay, wherein (A) illustrates three BNCs, (B) multiple apoptotic cells, 
(C) and (D) BNCs with one MNi, (E) a BNC with multiple MNi, and (F) a BNC with four MNi. White arrows 
indicate MNi within BNCs and blue arrows indicate possible apoptotic events.  
 
Figure 3.17: MCF-7 cells after CBMN assay, wherein (A) illustrates two BNCs, (B) a number of MNi with 
BNCs, (C) two BNCs; one cell containing one MNi, (D) two BNCs both having two MNi, (E) a number of MNi 
with BNC, and (F) two BNCs with two and four MNi, respectively. White arrows indicate MNi within BNCs 
and the pink arrow indicates an anaphase bridge.  
Multiple cells showing characteristic apoptotic features were observed in CHO-K1 cells (Fig. 
3.16 B) due to high-LET exposure. Based on the stained images of CHO-K1 and MCF-7 cells 
treated with non-irradiated or irradiated 10 nm AuNPs (Fig. 3.16 E, F & Fig. 3.17 E, F), 
resulted in more MNi, than cells treated with non-irradiated or irradiated 5 nm AuNPs (Fig. 
3.16 C, D & Fig. 3.17 C, D). 
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3.3.2 Quantification of cellular kinetics and MNi  
 
 
 
Figure 3.18: (A) Cellular kinetics of the CHO-K1 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 2 Gy X-rays showed 
an overall decrease in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi 
present determined via the CBMN assay in CHO-K1 cells after 4 hour incubation with 50 µg/ml AuNPs 
followed by 2 Gy X-ray radiation. Control cells treated with AuNPs showed a small number of MNi, whilst 
significant increase of MNi within cells treated with AuNPs and radiated with 2 Gy X-rays was apparent. The 
interaction indices for AuNPs and 6 MV X-rays in CHO-K1 cells are 1.6 to 1.7, thus > Unity (Unity = 1). 
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Figure 3.19: (A) Cellular kinetics of the BEnd5 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 2 Gy X-rays showed 
an overall decrease in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi 
present determined via the CBMN assay in BEnd5 cells after 4 hour incubation with 50 µg/ml AuNPs followed 
by 2 Gy X-ray radiation. Control cells treated with AuNPs showed a negligible number of MNi, whilst a 
noticeable increase of MNi within cells treated with AuNPs and radiated with 2 Gy X-rays was apparent. The 
interaction indices for AuNPs and 6 MV X-rays of 0.92 to 1.06 determined for BEnd5 cells was differed from 
Unity (Unity = 1). 
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Figure 3.20: (A) Cellular kinetics of MCF-7 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 2 Gy X-rays showed 
an overall decrease in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi 
present determined via the CBMN assay in MCF-7 cells after 4 hour incubation with 50 µg/ml AuNPs followed 
by 2 Gy X-ray radiation. Control cells treated with AuNPs displayed an insignificant number of MNi, whilst an 
outspoken increase of MNi within cells treated with AuNPs and radiated with 2 Gy X-rays was apparent. The 
interaction indices for AuNPs and 6 MV X-rays of 1.3 to 1.4 were determined for MCF-7 cells, which is > 
Unity (Unity = 1). 
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Figure 3.21: (A) Cellular kinetics of MCF-10A cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs, excluding cells treated with 10 nm AuNPs 
and/or irradiated with 2 Gy X-rays showed an overall decrease in cellular kinetics in comparison to the control. 
(B) Mean cumulative frequency of MNi present determined via the CBMN assay in MCF-10A cells after 4 hour 
incubation with 50 µg/ml AuNPs followed by 2 Gy X-ray radiation. Control cells treated with AuNPs showed 
an insignificant number of MNi in control, whilst a noticeable increase of MNi within cells treated with AuNPs 
and radiated with 2 Gy X-rays was apparent. The interaction indices for AuNPs and 6 MV X-rays of 0.87 to 
0.97 determined for MCF-10A cells, which is < Unity (Unity = 1). 
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Cellular kinetics of abovementioned cells (Fig. 3.18 A, 3.19 A, 3.20 A & 3.21 A) decreased 
in the presence of 50 µg/ml AuNPs. The 5 nm AuNPs decreased the cellular kinetics of 
CHO-K1 cells by 57.5%, followed by the MCF-10A cells (33.75%), the BEnd5 cells 
(32.75%), and with the lowest effect (23%) on the MCF-7 cells. The 10 nm had the greater 
effect (46.25%) on CHO-K1 cells and a lesser effect on MCF-10A cells (12.75%). Overall, 
irradiated control and irradiated AuNPs yielded a great number of MNi in comparison with 
non-irradiated samples (Fig. 3.18 B, 3.19 B, 3.20 B & 3.21 B).  
 
An interaction is determined, as follow, MNi numbers are higher when induced by a 
combination treatment of radiation and AuNPs compared to the additive sum of MNi 
numbers noted in samples exposed to AuNPs and radiation separately. Interaction indices can 
also be known as enhancement factor. A significant interaction between the scattered 6 MV 2 
Gy X-rays and AuNPs was only seen in CHO-K1 (non-malignant) and MCF-7 cells 
(malignant). For this reason, further experiments on radiation damage were conducted in 
these cell lines only. These experiments include a change in AuNPs concentration, X-ray 
dose and the inclusion of p(66)/Be neutron radiation.  
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Figure 3.22: (A) Cellular kinetics of CHO-K1 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 4 Gy X-rays showed 
an overall decrease in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi 
present determined via the CBMN assay in CHO-K1 cells after 4 hour incubation with 50 µg/ml AuNPs 
followed by 4 Gy X-ray radiation. Control cells treated with AuNPs caused an insignificant number of MNi, 
whilst a clear increase of MNi within cells treated with AuNPs and radiated with 4 Gy X-rays was observed. 
The interaction indices for AuNPs and 6 MV 4 Gy X-rays of 1.04 to 1.13 have been determined for CHO-K1 
cells is lower than the interaction indices after 2 Gy, in comparison to 2 Gy X-rays. 
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Figure 3.23: (A) Cellular kinetics of MCF-7 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 4 Gy X-rays showed 
an overall decrease in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi 
present determined via the CBMN assay in MCF-7 cells after 4 hour incubation with 50 µg/ml AuNPs followed 
by 4 Gy X-ray radiation. Control cells treated with AuNPs displayed a few caused MNi, whilst an observable 
increase of MNi within cells treated with AuNPs and radiated with 4 Gy X-rays was apparent. The interaction 
indices for AuNPs and 4 Gy X-rays of 0.74 to 0.77 is lower than the interaction indices after 2 Gy X-rays. 
 
The 4 Gy dose of X-ray radiation had similar effects on the cellular kinetics of CHO-K1 and 
MCF-7 cells in comparison to the 2 Gy X-rays. Control cells treated with AuNPs displayed a 
few MNi, whilst an increase of MNi within BNCs incubated with irradiated AuNPs was 
apparent. However, the notable interaction between AuNPs and 2 Gy scattered X-ray 
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radiation in CHO-K1 and MCF-7 (Fig. 3.18 B & 3.20 B) did not exist in addition to a higher 
radiation dose of 4 Gy X-rays (Fig. 3.22 B & 3.23 B). 
 
 
 
Figure 3.24: (A) Cellular kinetics of CHO-K1 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 2.5 µg/ml AuNPs and/or irradiated with 2 Gy X-rays showed 
no change in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi present 
determined via the CBMN assay in CHO-K1 cells after 4 hour incubation with 2.5 µg/ml AuNPs followed by 2 
Gy X-ray radiation. The radiated samples treated with AuNPs showed a number of MNi, but no difference 
between the control and the AuNP treated samples were observed. The interaction indices for AuNPs and 2 Gy 
X-rays of 0.89 to 1.00 is lower than the interaction indices after 50 µg/ml AuNPs. 
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Figure 3.25: (A) Cellular kinetics of MCF-7 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 2.5 µg/ml AuNPs and/or irradiated with 2 Gy X-rays showed 
no change in cellular kinetics in comparison to the control. (B) Mean cumulative frequency of MNi present 
determined via the CBMN assay in MCF-7 cells after 4 hour incubation with 2.5 µg/ml AuNPs followed by 2 
Gy X-ray radiation. A visible increase of MNi within cells treated with AuNPs and radiated with 2 Gy X-rays 
was evident in comparison to the radiated control. The interaction indices for AuNPs and 2 Gy X-rays of 1.10 to 
1.19 are lower than the interaction indices after 50 µg/ml AuNPs. 
 
A previous study conducted by Jain et al (2011) used a lower concentration of 12 µm of 
AuNPs and AuNPs radiosensitisation was observed in MDA-MB-231 cells (human breast 
cancer cell line) at 6 MV photon energies. The experiments by Jain et al. (2011) were carried 
out at 12 μM AuNP concentrations with 24 hour incubation. For this reason, lower 
concentration with longer exposure period could result in enhanced interaction between 
AuNPs and scattered 6 MV 2 Gy X-ray radiation. The irradiated 5 nm AuNPs (2.5 µg/ml) 
reduced the cellular kinetics of CHO-K1 was reduced by 16% (Fig. 3.24A), whereas the 
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cellular kinetics of MCF-7 was reduced between 30–38% (Fig. 3.25A). CHO-K1 and MCF-7 
cells were treated with a lower concentration of AuNPs (2.5 µg/ml) followed by 2 Gy X-ray 
radiation to determine if the interaction between AuNPs and X-ray radiation would still exist. 
The interaction indices were less than Unity (Unity = 1), in comparison to the 50 µg/ml of 
AuNPs.  
 
 
Figure 3.26: Cellular kinetics and MNi frequency of CHO-K1 cells. (A) Cellular kinetics of CHO-K1 cells 
was determined by scoring 400 AO stained BNCs and expressed as a percentage (%). Cells treated with 50 
µg/ml AuNPs and/or irradiated with 1 Gy p(66)/Be neutrons showed an overall decrease in cellular kinetics in 
comparison to the control. (B) Mean cumulative frequency of MNi present were determined via the CBMN 
assay in CHO-K1 cells after 4 hour incubation with 50 µg/ml AuNPs followed by 1 Gy p(66)/Be neutrons. 
Control cells treated with AuNPs displayed an insignificant number of MNi, whilst a visible increase of MNi 
within cells treated with AuNPs and radiated with 1 Gy p(66)/Be neutrons was evident. The interaction indices 
for AuNPs and 1 Gy p(66)/Be neutrons of 1.06 to 1.16 is lower than the interaction indices after 2 X-rays. 
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Figure 3.27: (A) Cellular kinetics of MCF-7 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs showed a decrease in cellular kinetics in 
comparison to the control, whilst the irradiated cells with 1 Gy p(66)/Be neutrons did not differ from the 
radiated control. (B) Mean cumulative frequency of MNi present determined via the CBMN assay in MCF-7 
cells after 4 hour incubation with 50 µg/ml AuNPs followed by 1 Gy p(66)/Be neutrons. No difference in the 
number of MNi within cells treated with AuNPs and radiated with 1 Gy p(66)/Be neutrons and the radiated 
control was noticeable. The interaction indices for AuNPs and 1 Gy p(66)/Be neutrons of 0.88 to 0.95 is lower 
than the interaction indices after 2 Gy X-rays. 
 
The cellular kinetics of CHO-K1 and MCF-7 were not affected as expected and observed in 
Fig. 3.14 & Fig. 3.15. Control cells treated with AuNPs displayed an insignificant number of 
MNi, whilst a visible increase of MNi within cells treated with irradiated (1 Gy p(66)/Be 
neutrons) AuNPs was evident. However, the interaction between the irradiated in CHO-K1 
(non-malignant) and MCF-7 cells (malignant) was not significant (Fig. 3.26 B & 3.27 B).  
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
Control  IR Control  5 nm AuNPs  IR 5 nm AuNPs  10nm AuNPs  IR 10 nm 
AuNPs  
%
  
o
f 
 C
el
lu
la
r 
K
in
et
ic
s 
 
Treatment 
A 
0 
100 
200 
300 
400 
500 
600 
700 
800 
900 
Control  IR Control  5 nm AuNPs  IR 5 nm AuNPs  10 nm AuNPs  IR 10 nm 
AuNPs  
T
o
ta
l 
n
u
m
b
er
 o
f 
M
N
i 
 
Treatment 
B 
 
 
 
 
66 
 
 
 
Figure 3.28: (A) Cellular kinetics of CHO-K1 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 2 Gy p(66)/Be 
neutrons showed an overall decrease in cellular kinetics in comparison to the control. (B) Mean cumulative 
frequency of MNi present determined via the CBMN assay in CHO-K1 cells after 4 hour incubation with 50 
µg/ml AuNPs followed by 2 Gy p(66)/Be neutrons. All the samples radiated with 2 Gy p(66)/Be neutrons 
showed an increase in the number of MNi, however no clear increase was observed in the samples treated with 
AuNPs. The interaction indices for AuNPs and 2 Gy p(66)/Be neutrons of 1.00 to 1.02 is lower than he 
interaction indices after 2 Gy X-rays.   
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Figure 3.29: (A) Cellular kinetics of MCF-7 cells was determined by scoring 400 AO stained BNCs and 
expressed as a percentage (%). Cells treated with 50 µg/ml AuNPs and/or irradiated with 2 Gy p(66)/Be 
neutrons showed a small decrease in cellular kinetics in comparison to the control. (B) Mean cumulative 
frequency of MNi present determined via the CBMN assay in MCF-7 cells after 4 hour incubation with 50 
µg/ml AuNPs followed by 2 Gy p(66)/Be neutrons. Control cells treated with AuNPs showed an irrelevant 
number of MNi. No difference between the radiated control and the AuNPs samples after 2 Gy p(66)/Be 
neutrons – was obvious. The interaction indices for AuNPs and 2 Gy p(66)/Be neutrons of 0.86 to 0.94 is lower 
than the interaction indices after 2 Gy X-rays.  
 
The interaction indices between AuNPs and 2 Gy p(66)/Be neutrons is lower (Fig. 3.28 B & 
3.29 B), in comparison to the interaction indices between AuNPs and 2 Gy X-rays, as 
p(66)/Be neutrons do not interact with AuNPs. Thus, no interaction was observed between 
AuNPs and p(66)/Be neutron radiation (Loveland et al., 2006; De Beer, 2015). 
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3.4 Cell viability assays 
 
The MTT assay was used to assess the overall toxicity of the AuNPs on the CHO-K1, BEnd5, 
MCF-7 and MCF-10A cell lines. 
 
Figure 3.30: Box-and-Whisker plots showing the % cell viability in CHO-K1 cells as determined by MTT 
in 96 well plates. (A) Cells incubated with AuNPs for 4 hours, (B) cells incubated with AuNPs for 4 hours 
followed by 4 Gy 6 MV X-ray radiation, and (C) cells incubated with AuNPs for 24 hours. 5 and 10 nm AuNPs, 
at 50 µg/ml, caused a significant decrease in cell proliferation (p < 0.05) in all three different conditions, namely 
A, B and C (Addendum: Tables  5.4–5.6). 
 
 
 
 
69 
 
 
Figure 3.31: Box-and-Whisker plots showing the % cell viability in CHO-K1 cells as determined by MTT 
in 96 well plates. (A) Cells incubated with AuNPs for 4 hours, (B) cells incubated with AuNPs for 4 hours 
followed by 4 Gy X-ray radiation, and (C) cells incubated with AuNPs for 24 hours. 5 and 10 nm AuNPs, at 50 
µg/ml, caused a significant decrease in cell proliferation (p < 0.05) in all three different conditions, namely A, B 
and C (Addendum: Tables 5.7–5.9). 
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Figure 3.32: Box-and-Whisker plots showing the % cell viability in MCF-7 cells as determined by MTT in 
96 well plates. (A) Cells incubated with AuNPs for 4 hours, (B) cells incubated with AuNPs for 4 hours 
followed by 4 Gy X-ray radiation, and (C) cells incubated with AuNPs for 24 hours. 5 and 10 nm AuNPs, at 50 
µg/ml, caused a significant decrease in cell proliferation (p < 0.05) in all three different conditions, namely A, B 
and C (Addendum: Tables 5.10–5.12).  
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Figure 3.33: Box-and-Whisker plots showing the % cell viability in MCF-10A cells as determined by 
MTT in 96 well plates. (A) Cells incubated with AuNPs for 4 hours, (B) cells incubated with AuNPs for 4 
hours followed by 4 Gy X-ray radiation, and (C) cells incubated with AuNPs for 24 hours. 5 and 10 nm AuNPs, 
at 50 µg/ml, caused a significant decrease in cell proliferation (p < 0.05), except in condition C (Addendum: 
Tables 5.13–5.15). 
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Based on results from Fig. 3.30–3.33 a decreased in cell toxicity was observed in each cell 
lines exposed to 50 µg/ml of both types of AuNPs for 4 hours and followed by 4 Gy X-ray 
radiation. A significant decreased in cell survival was observed in each cell lines exposed to 
50µg/ml of both types of AuNPs for 24 hours (Addendum: Table 5.3–5.13).  
 
3.5 Flow cytometry  
 
Flow cytometry was employed to analyse the effect of AuNPs alone, and with 2 Gy X-ray 
radiation on the cell cycle progression of CHO-K1, BEnd5, MCF-7 and MCF-10A cells (Fig. 
3.34–3.37). The investigation was conducted by ethanol fixation and propidium iodine (PI) 
staining of cells. PI was utilised to stain the nucleus in order to determine the amount of DNA 
present. Tables 3.1–3.4 show the percentage cells in various cell cycle phases.  
 
 
Figure 3.34: Flow cytometry was used to investigate the cell cycle progression in CHO-K1 cells. The DNA 
histograms show the effect of AuNPs on the CHO-K1 cells after a 4 hour exposure period, followed by 2 Gy X-
ray radiation. (A) non-radiated control, (B) irradiated control, (C) non-radiated cells with 50 µg/ml of 5 nm 
AuNPs, (D) cells with 50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells with 50 µg/ml of 10 nm AuNPs 
and (F) cells with 50 µg/ml irradiated 10 nm AuNPs. 
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Figure 3.36: Flow cytometry was used to investigate the cell cycle progression in MCF-7 cells. The DNA 
histograms show the effect of AuNPs on the MCF-7 cells after a 4 hour exposure period, followed by 2 Gy X-
ray radiation. (A) non-radiated control, (B) irradiated control, (C) non-radiated cells with 50 µg/ml of 5 nm 
AuNPs, (D) cells with 50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells with 50 µg/ml of 10 nm AuNPs 
and (F) cells with 50 µg/ml irradiated 10 nm AuNPs. 
Figure 3.35: Flow cytometry was used to investigate the cell cycle progression in BEnd5 cells. The DNA 
histograms show the effect of AuNPs on the BEnd5 cells after a 4 hour exposure period, followed by 2 Gy X-
ray radiation. (A) non-radiated control, (B) irradiated control, (C) non-radiated cells with 50 µg/ml of 5 nm 
AuNPs, (D) cells with 50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells with 50 µg/ml of 10 nm 
AuNPs and (F) cells with 50 µg/ml irradiated 10 nm AuNPs. 
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Figure 3.37: Flow cytometry was used to investigate the cell cycle progression in MCF-10A cells. The 
DNA histograms show the effect of AuNPs on the MCF-10A cells after a 4 hour exposure period, followed by 2 
Gy X-ray radiation. (A) non-radiated control, (B) irradiated control, (C) non-radiated cells with 50 µg/ml of 5 
nm AuNPs, (D) cells with 50 µg/ml irradiated 5 nm AuNPs, (E) non-radiated cells with 50 µg/ml of 10 nm 
AuNPs and (F) cells with 50 µg/ml irradiated 10 nm AuNPs. 
 
Table 3.1: Shows the percentage distribution of CHO-K1 controls, AuNPs and irradiated AuNPs treated 
cells in the different cell cycle phases. PI staining detected by flow cytometry was utilized to investigate the 
effects of AuNPs and X-ray radiation on the cell cycle distribution.  DNA content analysis showed a significant 
increase in the number of CHO-K1 cells in the S phase (38.2%) and in the G2/M phase (37.9%), after radiation, 
when compared to the control cells in S (27.4%) and G2/M (28.2%) (Fig. 3.34 A & B). Exposure to 5 and 10 nm 
AuNPs respectively increased the number of cells in G2/M (37.3% and 42.5%) when compared to control cells 
(Fig 3.34 C & E). Radiated cells with 5 nm AuNPs increased the number of cells in the G2/M phase even more 
(48.1%) and the cells treated with 10 nm AuNPs showed an increase in the S phase (42.4%).  
Cell 
types 
Time Cell 
cycle 
phase 
Control Irradiated 
(IR) 
control 
50 
µg/ml 
of 5 nm 
AuNPs 
50 
µg/ml 
of IR 5 
nm 
AuNPs 
50 
µg/ml 
of 10 
nm 
AuNPs 
50 
µg/ml of 
IR 10 
nm 
AuNPs 
C
H
O
-K
1
 
4 H 
G1 44.9 25.0 44.9 29.4 31.5 15.8 
S 27.4 38.2 18.2 22.3 27.3 42.4 
G2 28.2 37.9 37.3 48.1 42.5 41.9 
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Table 3.2: Shows the percentage distribution of BEnd5 controls, AuNPs and irradiated AuNPs treated 
cells in the different cell cycle phases. DNA content analysis displayed a significant increase in the number of 
BEnd5 cells in the G2/M phase (28.2%) after radiation when compared to the control cells in G2/M (21.9%) 
(Fig. 3.35 A & B). No major difference in number of cells in S phase (15.3%), after radiation, when compared 
to control cells were observed (Fig. 3.34 A & B). Exposure to 5 and 10 nm AuNPs respectively increased the 
number of cells in G2/M (34.1% and 35.4%) when compared to control cells (Fig 3.35 C & E).  
Cell 
types 
Time Cell 
cycle 
phase 
Control Irradiated 
(IR) 
control 
50 
µg/ml 
of 5 nm 
AuNPs 
50 
µg/ml 
of IR 5 
nm 
AuNPs 
50 
µg/ml 
of 10 
nm 
AuNPs 
50 
µg/ml 
of IR 10 
nm 
AuNPs 
B
E
n
d
5
 
4 H 
G1 63.4 55.7 57.4 55.8 51.2 48.6 
S 15.5 15.3 7.4 10.8 12.8 13.0 
G2 21.9 28.2 34.1 33.7 35.4 36.4 
 
 
 
Table 3.3: Shows the percentage distribution of MCF-7 controls, AuNPs and irradiated AuNPs treated 
cells in the different cell cycle phases. PI staining detected by flow cytometry was utilized to investigate the 
effects of AuNPs and X-ray radiation on the cell cycle distribution.  DNA content analysis showed a significant 
increase in the number of MCF-7 cells in the G2/M phase (51.7%), after radiation, when compared to the control 
cells G2/M (33.7%) (Fig. 3.36 A & B). Exposure to 5 and 10 nm AuNPs respectively increased the number of 
cells in G2/M (45.7% and 47.1%) when compared to control cells in G2/M phase (33.7%). Cells incubated with 
5 nm AuNPs, followed by 2 Gy X-ray radiation showed a significant increased the number of cells in the G2/M 
phase (63.2%) when compared to control cells in G2/M phase (33.7%). Cells exposed to 10 nm AuNPs and 
irradiated 10 nm AuNPs displayed a small decrease in the number of cells (47.5% and 45.5%, respectively) (Fig. 
3.36 E & F). 
Cell 
types 
Time Cell 
cycle 
phase 
Control Irradiated 
(IR) 
control 
50 
µg/ml 
of 5 nm 
AuNPs 
50 
µg/ml 
of IR 5 
nm 
AuNPs 
50 
µg/ml 
of 10 
nm 
AuNPs 
50 
µg/ml of 
IR 10 
nm 
AuNPs 
M
C
F
-7
 
4 H 
G1 47.7 26.0 42.9 23.1 29.5 27.0 
S 20.1 23.7 13.0 13.3 22.3 30.3 
G2 33.7 51.7 45.7 63.2 47.1 45.5 
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Table 3.4: Shows the percentage distribution of MCF-10A controls, AuNPs and irradiated AuNPs treated 
cells in the different cell cycle phases. DNA content analysis showed a significant increase in the number of 
MCF-10A cells in the S phase (20.4%) after radiation when compared to the control cells in S (10.4%) (Fig. 
3.37 A & B). Exposure to 5 and 10 nm AuNPs respectively increased the number of cells in G2/M (37.3% and 
42.5%) when compared to control cells (Fig 3.34 C & E). Radiated cells with 5 nm and 10 nm AuNPs 
respectively increased the number of cells in the S phase (22.5% & 17.6 %) when compared to the control S 
phase (10.4%).  
Cell 
types 
Time Cell 
cycle 
phase 
Control Irradiated 
(IR) 
control 
50 
µg/ml 
of 5 nm 
AuNPs 
50 
µg/ml 
of IR 5 
nm 
AuNPs 
50 
µg/ml 
of 10 
nm 
AuNPs 
50 
µg/ml of 
IR 10 
nm 
AuNPs 
M
C
F
-1
0
A
 
4 H 
G1 68.4 57.0 64.2 52.8 60.6 59.1 
S 10.4 20.4 12.4 22.5 17.6 16.5 
G2 20.6 23.7 22.4 25.2 22.8 23.9 
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CHAPTER 4: 
DISCUSSION 
 
 
4.1 Introduction 
 
The main aspect of this study was to investigate and contrast the effect of AuNPs between 
breast cancer cells and non-malignant CHO-K1, Bend5 and MCF-10A cells. The focus has 
been turned to the preparation and application of nanoparticles for cancer therapy with 
emphasis on the dose enhancement effect of AuNPs and the therapeutic potential of AuNPs 
in radiation therapy of cancer (Berbeco et al., 2012; Kumar et al., 2013; Abolfazli et al., 
2015).  
 
Dose enhancements can be accomplished by introducing a high atomic (Z) mass contrast 
agent, such as gold, that provide the greatest probability for photo interactions by 
photoelectric effect, when radiated by low energy X-rays (Spiers, 1949; Matsudaira et al., 
1980). The photoelectric interactions produce photoelectrons and Auger electrons which 
introduce a localised dose enhancement in cells. The Auger effect is greatest in atoms of 
medium and high atomic mass, wherein the Auger electrons act as α-particles producing high 
local ionisation density damage. In this study, cellular uptake of AuNPs and their effect on 
cell viability was investigated. In order to demonstrate a possible interaction between the X-
rays and AuNPs, an exceptionally high concentration of AuNPs was used and the 
chromosomal damage and changes in cellular kinetics were studied.  
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4.2 Characterisation of AuNPs  
 
The characterisation of AuNPs is significant to evaluate the nature of the AuNPs. Since, the 
interaction of ANPs plays an important role in their properties.  
 
4.2.1 UV-visible (vis) absorption spectrometry 
 
Surface plasmon resonance (SPR) is determined from absorption and scattering spectroscopy 
and is found to depend on the shape, size, and dielectric constants of both the metal and the 
surrounding material (Eutis & El-Sayed, 2005). Thus, increased particle size is noticeable 
with a peak shifting to a longer wavelength, whilst increased width of absorption spectra 
corresponds to the size distribution range (Verma et al., 2014; Peng et al., 2015). A slight 
peak shift of 10 nm AuNPs was observed, when compared to the peak of 5 nm AuNPs (Fig. 
3.1).  
 
The absorbance profile of 5 nm and 10 nm AuNPs as measured using UV-vis 
spectrophotometry is shown in Fig. 3.1. The λmax was between 500–565 nm, with SPR at 525 
nm for both types of AuNPs. The UV-vis absorption peaks observed corresponded to the 
excitation of SPR in AuNPs and provides as an affirmation of their presence. This gives a 
brilliant red colour to the AuNPs, which varies in relation to their size.  
 
4.2.2 Zeta (Z) potential dynamic light scattering (DLS) and polydispersity index (PDI) 
 
Z-potential provides essential information on the dispersion of nanoparticles, as the charge is 
an indication of the repulsion forces between particles that can be utilised to predict long-
term stability of the nanoparticles in suspension. Z-potential, DLS and PDI determination was 
used to assess the charge and hydrodynamic size as well as the size distribution width of the 
citrate-coated AuNPs (Fig. 3.2.1). The negative Z-potential charge of the AuNPs (from -24.5 
mV for 5 nm AuNPs to -23.2 mV for 10 nm AuNPs) represents the necessary repulsive 
forces for the particles to remain stable in solution (Addendum: Fig. 5.1). PDI data was 
employed to determine the size width distribution of the AuNPs. The PDI measurements 
ranged from 0.202–0.329 suggested that the AuNPs were uniform in size (Fig. 3.2.2). The Z-
average size/DLS (diameter in nm) was 38.12 nm and 48.50 nm, respectively for 5 nm and 10 
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nm AuNPs (Fig. 3.2.2) (Addendum: Fig. 5.2). It is known that smaller AuNPs tend to 
aggregate (Bhirde et al., 2014; Collado-González et al., 2015) and the hydrodynamic size of 
the 10 nm AuNPs (Fig. 3.2.2) was greater than the core size measured by TEM (Fig 3.3 G). 
The aggregates seen in TEM images could be attributed to the drying process during sample 
preparation. DLS measures the hydrodynamic radius of the AuNPs, whereas by TEM 
measurement is an estimated value of the projected area diameter. As a dispersed AuNP 
moves through a liquid medium, a thin electric dipole layer of the solvent adheres to its 
surface. This layer influences the movement of the particle in the medium as a result the 
hydrodynamic diameter provided information of the inorganic core along with any coating 
material and the solvent layer attached to the AuNP as it moved under the influence of 
Brownian motion, whereas the hydration layer is not present in the TEM measurement. Thus, 
only measurement of the inorganic core of AuNPs was obtained. Larger particles will diffuse 
slower than smaller particles and the DLS instrument measures the time dependence of the 
scattered light to generate a correlation function that can be mathematically linked to a 
particle size (Kumar & Kumbhat, 2016).The AuNPs were coated with citrate ions which act 
as stabilising agents via electrostatic repulsion (Zhou et al., 2009), but could still aggregate in 
a solution with sufficiently high ionic strength or low pH (Jia et al., 2014; Pamiés et al., 
2014), thus possible and consistent with 5 and 10 nm sizes. 
 
4.2.3 Transmission electron microscopy (TEM)  
 
The transmission electron microscopy confirmed that 10 nm AuNPs were indeed 0.01 µm (10 
nm) (Fig. 3.3 G) and that the AuNPs were in a monodispersional state, presumably due to 
negatively charged citrate ions on the surface of the nanoparticles. The internalisation of 
AuNPs can occur in various ways such as, phagocytosis, micropinocytosis and receptor-
mediated endocytosis depending on size, type, cell receptors and cellular signalling cascades 
of AuNPs (Conner & Schmid, 2003; Chithrani et al., 2006). These mechanisms for 
nanoparticle internalisation include the formation of AuNP-protein complexes, recognition by 
cell membrane receptors, engulfment into a vesicle by the cells, being transported or 
penetrating into cells, the activation of signal pathways, and storage or removal of AuNPs by 
cells (Wang et al., 2015).  
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Vesicle transportation of AuNPs (Fig. 3.3 A–L) was observed in both the MCF-7 and MCF-
10A cells. Previous studies found that the intracellular uptake of AuNPs into cells are highly 
reliant on nanoparticles properties such as size, shape and surface coatings (Chithrani et al., 
2006; Chithrani, 2010; Freese et al., 2012; Neshatian et al., 2014; Kodiha et al., 2015).  
Extensive vesicle formation or possible autophagosomes containing AuNPs were observed in 
MCF-10A cells (Fig. 3.3 H, I & L), whereas in the MCF-7 cells AuNPs were observed only 
in the cytoplasm and in close proximity to the nuclear membrane (Fig. 3.3 E & F) implicating 
cellular damage, but no damage to the nucleus of the cell.  
 
Nanoparticles with sizes larger than 500 nm have been known to enter phagocytic cells via 
phagocytosis pathways and smaller particles enter via the receptor-mediated endocytosis 
(RME) pathways (Dobrovolskaia and McNeil 2007; Hess and Tseng 2007; Oh & Park, 
2014). However, a contradicting study reported that the internalisation of AuNPs smaller than 
100 nm also occurred via phagocytosis (França et al., 2011). Ryan et al. (2007) investigated 
the ability of 5 nm citrate-coated AuNPs to enter the nucleus of HeLa cells. Only 25% of the 
internalised AuNPs were able to enter the nucleus. After conjugating a nuclear-penetrating 
peptide to the AuNPs, 50% of internalised AuNPs were able to enter the nucleus in HeLa 
cells. Nanoparticles with a negative Z-potential have been reported to exhibit no cellular 
internalisation of nanoparticles (Gratton et al., 2008). The AuNPs used in this study were 
negatively charged, regarded as anionic AuNPs and expected to show minor or no interaction 
with the negatively charged surface of the cell. Internalisation of AuNPs was observed in 
both the MCF-7 and MCF-10A cells indicating that anionic AuNP’s uptake was mediated by 
non-specific adsorption of serum proteins onto the gold surface (protein corona), which 
allowed the nanoparticles to enter the cells via receptor-mediated endocytosis (Yen et al., 
2009; Logan, 2013; Cheng et al., 2015). Another factor that influences the internalisation of 
AuNPs, besides size and Z-potential, is the temperature. Cellular uptake of nanoparticles 
decreases by 70% at 4 °C, when compared 37 °C. At 4 °C, nanoparticles form clusters on the 
outer cell membrane because endocytotic actions starts to cease, whereas at 37 °C 
nanoparticles begin to accumulate intracellular compartments of the cell (Luciani et al., 
2009). All cells incubated with AuNPs in this study were incubated at 37 °C, 5% CO2 air and 
relative humidified atmosphere.  
 
AuNPs distributed in a biological fluid quickly bind to biomolecules, such as proteins and 
lipids, forming a protein corona on the AuNPs surface (Aggarwal et al., 2009; Monopoli et 
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al., 2012). These corona biomolecules can interact with membrane receptors to induce cell-
signalling (Deng et al., 2011). Nanoparticle uptake commences with an initial adhesion of the 
nanoparticles to the cell and interactions with the lipids, proteins, and other components of 
the cell membrane followed by the activation of an energy-dependent uptake mechanism 
(Chithrani et al., 2006; Dausend et al., 2008) which allows the nanoparticles to be internalised 
into the cell and additionally trafficked to different sub-cellular areas, normally ending in 
lysosomal accumulation (Lesniak et al., 2012) (Fig. 3.3 B, D & F). Lysosomes are central for 
degradation and recycling of macromolecules delivered by endocytosis, phagocytosis and 
autophagy (Appelqvist et al., 2013). Once the particles are endocytosed, they may be 
degraded in the endolysosomal compartment, or can trigger binding of nanoparticles to 
intracellular targets, thus causing disturbances in cellular signalling, motility and metabolism 
(Pan et al., 2007; Baudoin et al., 2013; Xiang & Zhang, 2013; Paunescu et al., 2014). A 
variety of nanoparticles (e.g. quantum dots, iron oxide, gold, silica, titanium dioxide and 
carbon) have been reported to induce autophagy (Stern et al., 2012; Peynshaert et al., 2014). 
In the mechanism of autophagy, a double-membrane structure engulfs protein aggregates, 
damaged organelles and other cellular components to form an autophagosome which fuses 
with lysosomes causing the formation of autolysosomes (Huang et al., 2015). Autophagy 
maintains cellular homeostasis under stressful conditions (e.g. nutrient deprivation, oxidative 
stress and hypoxia) to help the cells survive (Mizushima & Komatsu, 2011; Murrow & 
Debnath, 2013).  
 
Taking into consideration the various reports of AuNPs resulting in the induction of reactive 
oxygen species (ROS) in cells, it is possible that elevated ROS can result in mitochondrial 
swelling, mitochondrial depolarisation and DNA damage leading to necrosis or apoptosis 
(Tiwari et al., 2002; Peng & Jou, 2004; Butterworth et al., 2010; Yildirimer et al., 2011; 
Zorov et al., 2014). Swollen mitochondria were noted in the MCF-10A cells (Fig. 3.3 H–J), 
but not in MCF-7 cells. This is possibly due to oxidative stress and cytotoxicity of the AuNPs 
as it has been shown that AuNPs sometimes impair mitochondrial function (Wang et al., 
2013; Ding et al., 2014). Taggart et al. (2014) demonstrated that 1.9 nm AuNPs (500µg/ml) 
caused oxidation of the mitochondrial membrane protein, cardiolipin and cell specific 
disruption of mitochondrial membrane potential. The oxidation of cardiolipin initiates the 
intrinsic apoptotic pathway by releasing cytochrome c into the cytosol (Jiang et al., 2008). 
Both MDA-MB-231 (human breast adenocarcinoma) and T98G (human glioblastoma 
multiforma tumour) cells showed oxidation of cardiolipin in the presence of AuNPs. The 
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effect of AuNPs on the mitochondria might also be directly related to DNA damage upon the 
exposure to AuNPs, as mitochondria have been shown to play a role in the induction of DNA 
damage (Tartiet et al., 2007). 
 
4.3 γ-H2AX foci assay 
 
Previous studies reported that DNA DSBs induces H2AX phosphorylation and the number of 
γH2AX foci is directly related to the number of radiation-induced DNA DSBs (Hudson et al., 
2011; Murray et al., 2016). γH2AX foci formation can be considered as a consistent and 
quantitative marker of radiation-induced DNA DSBs (Vignard et al., 2013). H2AX is one of 
several genes coding for histone H2A, which can undergo phosphorylation, acetylation and 
ubiquitination to regulate the cellular events (Kumar et al., 2012). γ-H2AX phosphorylation 
assay is a quantification technique by definite immunoﬂuorescent staining that has been 
widely used to visualise the individual amount of DNA DSBs and is described as a highly 
sensitive method to monitor DSB induction and kinetics repair (Vujacic et al., 2011). 
 
Isolated lymphocytes incubated with AuNPs were irradiated with low doses (1 Gy X-ray and 
1 Gy p(66)/Be neutron) to prevent over-expression of foci, which can result in inaccurate 
automated scoring of foci per cell. The number of foci per cell increased slightly compared to 
the control. A significant increase in the number of foci was noticeable for cells treated with 
AuNPs followed by X-ray and p(66)/Be neutron radiation, respectively, compared to the 
control (Fig 3.4 & Fig. 3.5; Addendum: Table 5.3).  
 
A study conducted by Wiwanitkit et al. (2009) demonstrated that 9 nm citrate-coated AuNPs 
could enter lymphocytes. Since lymphocytes have no phagocytosis activity (Salaberria et al., 
2013) the known mechanism is the direct penetration of AuNPs into the cytoplasm of the 
lymphocyte (Wiwanitkit et al., 2009) substantiating the usefulness of nanoparticles as novel 
drug delivery systems to lymphocytes (Fahmy et al., 2007). According to this study, 
intracellular AuNPs could be observed in about 90.4 ± 8.5% of lymphocytes with no 
morphology changes when compared to control lymphocytes. However, the AuNPs could be 
seen in the cytoplasm, but not in the nucleus. In our study, the AuNPs could be seen mainly 
in the cytoplasm of MCF-7 and MCF-10A cells (Fig. 3.3 A–L). Wiwanitkit et al. (2009) 
suggested further researched into the penetration mechanism of AuNPs into the cytoplasm of 
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isolated lymphocytes as the lymphocyte membrane pore size at 4 nm x 2.5 nm, which was 
much smaller than the 9 nm AuNPs employed in the study.  
 
4.4 Cytokinesis-Block Micronucleus (CBMN) assay 
 
AuNPs are of interest for in vitro and in vivo applications in radiotherapy due to their well-
known biocompatibility (Klhebtsov et al., 2011; Jain et al., 2012) and effectiveness as 
radiosensitisers of low energy photons for the activation of the high K-edge of gold (80 keV) 
that can lead to the emission of short-range photoelectrons upon irradiation (200–500 kV 
range) (Berbeco et al., 2012; Hashmi et al., 2014). Hainfeld et al. (2004) was the first to show 
that intravenously administered 1.9 nm untargeted AuNPs accumulated and enhanced the 
radiation-induction death of mammary carcinomas in mice models when combined with 
kilovolt (kV) photon radiation. A Monte Carlo study predicted that the theoretical dose 
enhancement achieved by gold radiosensitisation is up to 200% or more (Cho, 2005; Hainfeld 
et al., 2008).  
 
Radiation induced damage can be measured by the CBMN assay. The visualisation of MNi 
within BNCs is represented in Figures 3.6–3.17. The consequences radiation induced DSBs 
may be observed as MNi containing acentric fragments from DNA. MNi are small, 
extracellular bodies resulting from chromosome breaks or lagging chromosomes during 
anaphase. Quantification of MNi within BNCs incubated for 4 hours with AuNPs and 
subsequently radiated with X-rays or p(66)/Be neutrons are shown in Figures 3.18 A–3.29 A. 
The percentage of cellular kinetics indicates the level of cellular division or growth rate 
undergone by each AuNPs treated sample with and without radiation. 
 
As expected, AuNPs reduced the cellular kinetics of CHO-K1, BEnd5, MCF-7 and MCF-
10A cell lines. MNi numbers for the non-radiated control samples were negligible, for all 
four cell lines. In the event of a radiosensitisation effect, the number of MNi of radiated cells 
treated with AuNPs should be higher than the controls (Fig. 3.18–3.21). Results showed that 
the non-malignant CHO-K1, BEnd5 and MCF-10A cells, as well as the malignant MCF-7 
cells incubated with AuNPs, were more sensitive to radiation damage. However, the CHO-
K1 and MCF-7 displayed significantly different interaction indices between the control cells 
and the 50 µg/ml AuNPs treated and radiated (scattered 6 MV 2 Gy X-ray) (Fig 3.6–3.9) 
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cells. Therefore, only CHO-K1 and MCF-7 cell lines were used for further experiments in 
this study.  
 
A higher dose of 4 Gy X-ray with 50 µg/ml of AuNPs in these two cell lines resulted in a 
high number of MNi in both the control and AuNP treated cultures, indicating that no 
interaction between AuNPs and 4 Gy X-rays took place (Fig 3.22–3.23). Corresponding 
fluorescent micrographs, Figures 3.10 and 3.11 displayed blebbing of cell membranes and the 
possible presence of apoptotic bodies. As the same phenomenon was not observed in the 
MCF-7 cells exposed to 2 Gy radiation (Fig. 3.8), it is possible that the presence of apoptosis 
is due to the higher radiation (4 Gy) dose. Apoptosis, or programmed cell death (PCD), is 
characterised by loss of cell to cell contact, detachment, cell shrinkage (loss of K
+
 and water) 
nuclear condensation, internucleosomal DNA cleavage (CAD-activation), nuclear 
fragmentation, membrane blebbing and cell-self-fragmentation into apoptotic bodies (Ouyang 
et al., 2012; Jain et al., 2013). In contrast to apoptosis (a non-physiological cell death), 
necrosis can lead to cytoplasm mitochondria swelling resulting in ATP depletion due to 
mitochondrial dysfunction (Denecker et al., 2001; Brenner & Moulin, 2012; Hayat, 2013). 
Mitochondria swelling were noted in MCF-10A cells incubated with 50 µg/ml of 10 nm 
AuNPs in TEM micrographs (Fig. 3.3 H–J), which could be indicative of the start of necrosis 
in these cells. The concentration of AuNPs used in this study was exceptionally high as 
determination of the radiation interaction indices with gold was the main aim. However, the 
high concentrations (50 µg/ml of AuNPs) did have a detrimental effect on cell morphology, 
as mentioned above, and cell viability especially in the 24 hour exposure periods, as shown in 
the MTT studies (Fig. 3.30–3.33).  
 
For comparison, CHO-K1 and MCF-7 cells were incubated for 4 hours with a much lower 
concentration of AuNPs (2.5 µg/ml) as employed in a study by Jain et al. (2011) to establish 
if a similar radiation interaction between AuNPs and the X-rays could be obtained. No 
significant interaction indices were present (Fig 3.24 & 3.25). This finding differs from the 
results obtained using the high concentration of AuNPs (50 µg/ml) suggesting that a 
significant interaction between AuNPs and X-rays were obtained, especially in the CHO-K1 
and MCF-7 cells.  Dividing CHO-K1 cells were observed after AuNPs treatment, illustrating 
that the low concentration did not affect the cellular division (Fig 3.12 C & F) compared to 
the higher concentration, while Figure 3.13 displayed a minute number of MNi within BNCs 
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of MCF-7. The low concentration AuNPs did not affect the cell division of either the non-
malignant CHO-K1 cells or the malignant MCF-7 cells. 
 
Ionising radiation (IR) interacts with DNA either directly or indirectly (Fig. 1.6), which 
damages cells either directly or indirectly through the production of free radicals causing 
DNA single or double-stranded breaks (DSBs). High-LET radiation damages the DNA 
directly by breaking hydrogen bonds connecting base pairs, whereas low-LET damages the 
DNA indirectly through radicals and reactive molecules (Hall & Giaccia, 2006). As a cell 
consists of 80% of water, IR often generates water radicals, as previously mentioned, by 
splitting a water molecule (H2O) into hydrogen ions (H
+
), hydroxyl radicals (OH
-
) or 
hydrogen peroxide (H2O2), which could initiate harmful chemical reactions in cells. High 
levels of ROS can cause damage to macromolecules, such as lipids, nucleic acids and 
proteins, leading to the induction lipid peroxidation (Cummings, 2006; Hernández et al., 
2015). A differential damage was expected, when AuNP-treated cells were irradiated with 
different doses of X-ray or neutron radiation. 
 
Figures 3.26–3.29 show a high number of MNi within BNCs of CHO-K1 and MCF-7 for 
both treatments of 50 µg/ml with 1 Gy or 2 Gy p(66)/Be neutron radiation (energy mean of 
29 MeV), respectively. No significant interaction was observed between the AuNPs and 
neutron radiation. Both, CHO-K1 and MCF-7 cells, after being treated with AuNPs (5 and 10 
nm) followed by 2 Gy p(66)/Be neutron radiation displayed many MNi (Fig. 3.17 B & E) and 
characteristic features of apoptosis, such as apoptotic bodies (Fig. 3.16 B) and cell blebbing 
(Fig 3.16 B). In this study, Auger electrons were definitely inferred, as well as free radicals 
and charged species (ROS). Low-LET X-ray-induced Auger electrons expected to be in the 
cells treated with 50 µg/ml of AuNPs, but a significant interaction between X-rays and 
AuNPs was only seen in CHO-K1 and MCF-7 cells. Auger electrons, which are weakly 
bound electrons cast out as a result of electronic shell rearrangements, can produce high local 
ionisation density. Several Auger electrons are generally emitted from the same atom 
simultaneously causing highly concentrated localised damage (Hainfeld et al., 2008; Kumar, 
2010). However, they travel much shorter distances, usually ~10 nm. The Auger effect is 
greater in atoms of medium and high Z, such as gold (Hainfeld et al., 2008). 
 
Different mechanisms of interaction between X-rays and nanoparticles, and neutrons and 
nanoparticles are expected according to the chemical nature of the nanoparticles, in this case 
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AuNPs. Gold (Au) has a high atomic number (Z=79) that enhances the photoelectric and thus 
the subsequent emissions of secondary electrons to increase conventional radiation therapy 
efficacy when bombarded with low voltage X-rays (Retif et al., 2015). The attenuation 
coefficient (cm
-1
) for 125 kV X-rays for gold is 35.95 and only 6.23 for neutrons (De Beer, 
2015). X-ray photons interact with the orbital electrons of atoms of the absorbing matter, 
namely AuNPs, and give of fast electrons. In contrast, neutrons interact with the nuclei of 
atoms of the absorbing matter (AuNPs) and set fast recoil protons, α-particles and heavier 
nuclear fragments in motion (Hall & Giaccia, 2006; Aktolun & Goldsmith, 2012). Thus, the 
lack of interaction between the AuNPs and the neutrons was expected (Loveland et al., 2006; 
De Beer, 2015). 
 
4.5 Cell viability assay 
 
Cell viability assays evaluate the overall toxicity of treatments such as AuNPs on cultured 
cells, by establishing cell survival and proliferation (Hillegas et al., 2010). It is important to 
know the dose of treatment required for a specific treatment. Many studies have reported 
non-toxicity of AuNPs (Conner et al., 2005; Shukla et al., 2005), but other researchers found 
AuNPs to have a toxic effect on cells (Goodman et al., 2004; Pan et al., 2007). It is known 
that metallic Au is non-toxic, but gold chloride or potassium gold cyanide is toxic to organs 
(Panyala et al., 2009). AuNPs are considered to be non-toxic as its core is inert (Bahadar et 
al., 2016). Previous studies suggest that cytotoxicity associated with AuNPs are dependent on 
concentrations, side chains, the stabiliser used, surface modifications, type of toxicity assay, 
cell line, and physical/chemical properties (Alkilany & Murphy, 2010; Arvizo et al., 2010; 
Yildirimer et al., 2011; Zhang et al., 2012; Yah, 2013; Favi et al., 2015; Pivodová et al., 
2015; Bahadar et al., 2016). The variation in toxicity with respect to different cell lines has 
been observed in a human lung and liver cancer cell line (Patra et al., 2007). AuNPs have 
many side-effects due to the interaction with cell membranes, mitochondria or the nucleus 
(Pivodová et al., 2015). 
 
Numerous drugs/medications are beneficial at low doses and toxic to cells at high doses. 
Several studies reported that the cytotoxicity of AuNPs is dose-dependent (Vajacic et al., 
2011; Freese et al., 2012; Vecchio et al., 2012; Fratoddi et al., 2014). In this study, AuNPs 
were found to have similar toxicity effects on the non-malignant cells (CHO-K1, BEnd5 and 
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MCF-10A) when compared to the malignant cell line (MCF-7). At a high concentration of 
AuNPs (50 µg/ml) a significant reduction (p < 0.05) in cell viability was seen in all four cell 
lines (Addendum: Tables 5.4, 5.7, 5.10 & 5.13). At lower concentrations (2.5, 5 and 10 
µg/ml) both the 5 and 10 nm AuNPs have no effect on the non-malignant cells (Fig. 3.30 A, 
3.31 A, 3.32 A & 3.33 A), but caused a slight decrease in the proliferation of MCF-7 cells 
(Fig. 3.31). Therefore, AuNPs might aid as a therapeutic advantage in breast cancer 
 
Cells incubated with 50 µg/ml AuNPs followed by 4 Gy X-ray radiation displayed a 
significant decrease (p < 0.05) (Addendum: Tables 5.3, 5.4, 5.9 & 5.12) in the cell viability of 
all the cell lines compared to the untreated control, (Fig. 3.30 B, 3.31 B, 3.32 B & 3.33 B). 
Overall, a significant (p < 0.05) decrease in cell viability was noted after 24 hour incubation 
with 50 µg/ml of AuNPs (Fig. 3.30 C, 3.31 C, 3.32 C & 3.33 C) in CHO-K1, BEnd5, MCF-7 
and MCF-10A cells (Addendum: Tables 5.6, 5.9, 5.12 & 5.15). 
 
Pivodová et al. (2015) conducted a cytotoxicity study of negatively charged AuNPs (-23.4 
mV) by a cell viability MTT assay. It was shown that AuNPs do not have a significant 
cytotoxic effect on normal human dermal fibroblasts (NHDF) and normal human epidermal 
keratinocytes (NHEK). However, in our study the negatively charged AuNPs had a 
significant increase in cell death at 50 µg/ml after 4 and 24 hours (Fig. 3.30–3.33). Previous 
studies reported that spherical citrate capped AuNPs (21 nm) do not have a toxic effect on 
human breast-cancer cell lines (MCF-7) or human prostate-cancer cell lines (PC-3), as well as 
the spherical citrate capped AuNPs (10–50 nm) are not toxic to human leukemic cells (K562) 
(Vijayakumar & Ganesan, 2012; Yah, 2013). 
 
Possible lysosomal bodies are illustrated in Fig. 3.3 B, D and F for MCF-7 cells as showed 
via TEM imaging. The latter was noted in cells treated with 50 µg/ml of 10 nm AuNPs. The 
observation led to the belief that the AuNPs were taken up via receptor-mediated endocytosis. 
Possible autophagosomes are also observed in MCF-7 (Fig. 3.3 A, D & E) and MCF-10A 
(Fig. 3.3 I & K). It is uncertain if the goal of these autophagosomes was cell survival or 
ultimately cell death, as it is known that a link between autophagy and apoptosis exists (Chen 
& Klionsky, 2011). Results of the MTT assay shows AuNPs can adversely affect cellular 
proliferation, probably by interacting with essential cell components including the nuclear 
membrane of the cell, mitochondria or nucleus. Adverse effects include organelle or DNA 
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damage, oxidative stress, apoptosis mutagenesis and protein up/down regulation (Alkilany et 
al., 2010; Söderstjerna et al., 2014; Khanna et al., 2015).  
 
4.6 Flow cytometry (Propidium iodide) 
 
Propidium iodide (PI) staining detected by flow cytometry was utilised to investigate the 
effects of 5 and 10 nm AuNPs followed by scattered 6 MV 2 Gy X-ray radiation. The latter 
allowed for the quantification of DNA content. Table 4.1 shows the cell progressions of the 
abovementioned cells, expressed as a percentage (%).  
 
Table 4.1: Flow cytometry. This latter was used to investigate cell cycle progression in CHO-K1, BEnd5, 
MCF-7 and MCF-10A cells.  
Cell 
types 
Time 
Cell 
cycle 
phase 
Control 
Irradiated 
(IR) 
control 
50 
µg/ml 
of 5 nm 
AuNPs 
50 
µg/ml 
of IR 5 
nm 
AuNPs 
50 
µg/ml 
of 10 
nm 
AuNPs 
50 
µg/ml of 
IR 10 
nm 
AuNPs 
C
H
O
-K
1
 
4 H 
G1 44.9 25.0 44.9 29.4 31.5 15.8 
S 27.4 38.2 18.2 22.3 27.3 42.4 
G2 28.2 37.9 37.3 48.1 42.5 41.9 
B
E
n
d
5
 
4 H 
G1 63.4 55.7 57.4 55.8 51.2 48.6 
S 15.5 15.3 7.4 10.8 12.8 13.0 
G2 21.9 28.2 34.1 33.7 35.4 36.4 
M
C
F
-7
 
4 H 
G1 47.7 26.0 42.9 23.1 29.5 27.0 
S 20.1 23.7 13.0 13.3 22.3 30.3 
G2 33.7 51.7 45.7 63.2 47.1 45.5 
M
C
F
-
1
0
A
 
4 H 
G1 68.4 57.0 64.2 52.8 60.6 59.1 
S 10.4 20.4 12.4 22.5 176 16.5 
G2 20.6 23.7 22.4 25.2 22.8 23.9 
 
 
G2/M phase is the most sensitive phase to irradiation and certain treatment can cause cells to 
accumulate in this phase leading to an increase in radiosensitisation (Choy et al., 1993; 
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Pawlik & Keyomarsi, 2004; Roa et al., 2009; Soule et al., 2010; Raviraj et al., 2014). In this 
study, cell cycle analysis by flow cytometry revealed cell cycle arrest of only CHO-K1 and 
MCF-7 cells in G2/M after 4 hour exposure to 50 µg/ml AuNPs (Fig. 3.34 B–C & Fig. 3.36 
B–F). A cell cycle synchronisation or arrest was observed at the G2M phase in the cell cycle 
of irradiated 5 nm AuNPs CHO-K1 and MCF-7 cells (Fig. 3.34), but no cell cycle arrest was 
noted in BEnd5 and MCF-10A cells (Fig. 3.35 & 3.37). The G2M cell cycle arrest can be 
associated with the interaction between the AuNPs and X-ray radiation, since only CHO-K1 
and MCF-7 cells displayed an interaction (Fig. 3.18 & Fig. 3.20). DNA content analysis 
showed a significant increase in the number of 10 nm AuNPs treated CHO-K1 cells in the S 
phase (42.4%) and in the G2/M phase (48.1%) after radiation (Fig. 3.34; Table 3.1 & 4.1). 
Exposure to 5 and 10 nm AuNPs respectively increased the number of cells in G2/M phase 
(45.7% and 47.1%) of the MCF-7 cell cycle, when compared to control cells in G2/M phase 
(33.7%) (Fig. 3.36 B & C). However, a significant increase (63.2%) was observed in the 
G2/M phase of the MCF-7 cells treated with 5 nm AuNPs and radiated (Table 3.3 & 4.1). 
According to Roa et al. (2009), AuNPs accumulated in prostate cancer cells (DU-145 cells) at 
the G2/M phase via the activation of both checkpoint kinases (CHK1 and CHK2). Thus, these 
results suggested that AuNPs may be utilised to enhance radiotherapeutic sensitisation effect 
in cancer therapy. p53, cyclin E, cyclin A and cyclin B were identified as being the major 
mediators of AuNPs-induced cell cycle changes resulting in a significantly increased 
expression of cyclin E and cyclin B1, and decreased expression of cyclin A. 
 
Cyclin E is a G1 cyclin and is the foremost regulator of the G1/S transition, wherein Cyclin E 
binds to CDK 2 leading to the formation of cyclin E-CDK 2 complex, which progresses the 
cell from the G1 to the S phase, described as the G1/S transition (Sanford & Parshad, 1999; 
Gérard & Goldbeter, 2009; Roa et al., 2009; Bertoli et al., 2013). As cells become dedicated 
to initiate division, the cells commence DNA replication and proceed to the S phase. These 
cells rely on specific checkpoints, as mentioned in Chapter 1, and can delay mitotic entry. 
DNA synthesis is mediated by the ATM and ATR protein kinases and CHK1 and/or CHK2, 
in which CHK1 is activated at the replication fork arrest in the S phase, whilst CHK2 is 
activated by damaged DNA detected during interphase (Jackson & Bartek, 2009; Brabzei & 
Foiani, 2010; Sorensen & Syljuasen, 2012). The CHK1 is necessary to avoid DNA damage 
with regards to replication stress during the S phase, whilst CHK2 is vital for the detection 
and repairing of DNA damage during interphase (Bartek & Lucas, 2003). The checkpoint 
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kinases caused the arrest of cell cycle progression via the regulation of cyclin-CDK activation 
(Bertoli et al., 2013).  
 
As a result, AuNPs (5 and 10 nm) in this study could have inhibited the expression of cyclin 
E to accelerate the G0/G1 phase and consecutively caused the accumulation of cells in the 
G2/M phase. After Roa et al. (2009) treated the DU-145 cells with glucose capped AuNPs 
(Glu-AuNPs), the expression of cyclin B1 by the cells was significantly increased (p < 0.05). 
This increase in cyclin B1 formed a cell accumulation in the G2/M phase (Roa et al, 2009). 
The build up in the G2/M phase was noted by the induction of 5 and 10 nm AuNPs that led to 
DNA damage. DNA damage activates the ‘guardian of the cell’, namely p53, which inhibits 
cyclin B expression and causes cell cycle arrest in the G2/M phase. A therapeutic agent, such 
as AuNPs, can be utilised to cause an accumulation in the G2/M phase to enhance radiation 
sensitivity (Roa et al., 2009; Babaei, M. & Ganjalikhani, 2014; Zhu et al., 2015). 
Furthermore, Saberi et al. (2016) observed no cell cycle arrest of HT-29 cells G2/M after 24 h 
exposed to 80 µM AuNPs possibly due to low AuNP concentration exposure. Consistently, 
Jain et al. (2011) showed that AuNPs do not affect the cell cycle arrest in MDA-MB-231 
cells. Conversely, SK-OV-3 cells that were incubated with 14.37 nm Glu-AuNPs were 
arrested in the G2/M phase (Geng et al., 2011). In contradiction, Liu et al. (2014) 
demonstrated that 5 nm AuNPs arrested the cell cycle at the G0/G1 phase in two lung cancer 
cell lines, namely A549 and 95D. Overall these data suggest that the effect of AuNPs on the 
cell cycle progression depend on the AuNPs size, concentration and the type of cells which is 
treated with AuNPs. 
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SUMMARY AND CONCLUSION 
 
 
 
In this study, the citrate-capped AuNPs of different sizes (5 nm and 10 nm) were investigated 
on the cytotoxicity in different cell lines, namely CHO-K1, Bend5, MCF-7 and MCF-10A, 
and the possible AuNPs interaction with X-ray and/or p(66)/Be neutron radiation for the 
enhancement of radiotherapy.  X-rays are a low LET radiation type, which were scattered by 
using a Shonka chamber to obtain lower energy X-rays to interact with the AuNPs. At 50 
µg/ml of AuNPs followed by scattered 6 MV 2 Gy X-rays only the CHO-K1 (non-malignant) 
and MCF-7 (malignant) cells showed an interaction above Unity (U > 1) implicating that 
AuNPs enhanced radiotherapy, whilst that for the other cell types used in the study were not 
different from Unity. The interaction was not present in CHO-K1 and MCF-7 cells, after a 
lower dose AuNPs (2.5µg/ml) and/or higher X-ray radiation dose (4 Gy). Furthermore, the 
interaction did not exist after 1 and 2 Gy 66)/Be neutron radiation exposure with AuNPs, 
respectively. However, the higher MNi frequencies were induced by a combination treatment 
of AuNPs and radiation compared to the additive sum noted in samples exposed to AuNPs 
and radiation separately. Still, the interaction indices were not present in some conditions. 
Although this experimental set-up was to exploit the generation of Auger electrons to 
increase MNi frequency, the results are not consistent with the DNA damage associated with 
Auger electron damage. This could be due to the fact that none of the AuNPs penetrated the 
nuclear membrane and some AuNPs were ‘captured’ in lysosomal and autophagosome 
bodies. The latter caused the AuNPs not to be close enough to the DNA to cause DNA 
damage associated with the α-particle like Auger electrons. 
 
The cellular kinetics of CHO-K1, BEnd5, MCF-7 and MCF-10A was reduced in all 
experimental conditions in comparison to the untreated control. Overall, the high 
concentration (50 µg/ml) of AuNPs reduced the cellular proliferation, whereas lower 
concentrations (2.5, 5 and 10 µg/ml) did not affect the cellular proliferation of the CHO-K1, 
BEnd5, MCF-7 and MCF-10A. The flow cytometry results showed that AuNPs caused a 
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G2/M arrest and it is known that cells in the G2/M phase is significantly more sensitive to 
irradiation. DNA damage activates the ‘guardian of the cell’, namely p53, which inhibits 
cyclin B expression and causes cell cycle arrest in G2/M phase. A therapeutic agent, such as 
AuNPs, can be utilised to cause an accumulation in the G2/M phase to enhance radiation 
sensitivity.  
 
The findings of this study demonstrated that AuNPs have a remarkable potential to enhance 
the radiosensitivity of CHO-K1 and MCF-7 cells at MV energy. In addition, the G2/M cell 
cycle arrest can be associated with the interaction between the AuNPs and X-ray radiation, 
since only CHO-K1 and MCF-7 cells displayed an interaction. Based on the results, the 
following conclusions were drawn: First, nanoparticle size is an essential variable affecting 
cellular kinetics, MNi frequency, DSBs in lymphocytes and cell progression. Second, in 
addition to particle size, cell type is also an essential aspect affecting the interaction between 
the AuNPs and radiation. Third, the G2/M arrest may be associated with radiotherapy dose 
enhancement by means of AuNPs. This study provides useful information on dose 
enhancement by AuNPs that could significantly improve radiotherapy outcomes, although the 
molecular mechanisms need further investigation.  
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ADDENDUM
 
 
 
Figure 5.1: Expert advice for the zeta potential measurements of AuNPs using Malvern Instruments’ 
Zetasizer Nano ZS. (A) represents the 5 nm AuNPs and (B) the 10 nm AuNPs. 
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Figure 5.2: Expert advice for the size measurements of AuNPs using Malvern Instruments’ Zetasizer 
Nano ZS. (A) represents the 5 nm AuNPS and (B) the 10 nm AuNPs. 
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Table 5.3:  Average number of foci per isolated human lymphocytes incubated with 50 µg/ml AuNPs for 4 
hours. Kruskal-Wallis test was used to determine the significant difference between the control means and 
experimental groups. 
Data Mean no. of foci cell 
Factor codes AuNPs 
Sample size 78 
Test statistic 68,3632 
Corrected for ties  Ht 68,3649 
Degrees of Freedom (DF) 8 
Significance level P < 0,000001 
 
Factor n Average Rank Different (P<0,05) 
from factor nr 
(1) 1 11 7,77 (2)(3)(4)(5)(6)(7)(8)(9) 
(2) 2 16 22,28 (1)(3)(4)(5)(6)(7)(8)(9) 
(3) 3 13 29,62 (1)(2)(4)(5)(6)(8)(9) 
(4) 4 11 48,82 (1)(2)(3)(5)(6)(8)(9) 
(5) 5 12 62,42 (1)(2)(3)(4)(7) 
(6) 6 9 68,44 (1)(2)(3)(4)(7) 
(7) 7 2 41,50 (1)(2)(5)(6)(8)(9) 
(8) 8 2 61,50 (1)(2)(3)(4)(7) 
(9) 9 2 73,00 (1)(2)(3)(4)(7) 
 
 
Table 5.4: % of cell viability in CHO-K1 cells incubated with 50 µg/ml AuNPs for 4 hours. Kruskal-Wallis 
test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 18,3704 
Corrected for ties  Ht 18,5059 
Degrees of Freedom (DF) 8 
Significance level P = 0,017737 
 
Factor n Average Rank Different (P<0,05) 
from factor nr 
(1) 1 3 18,00 (5)(8)(9) 
(2) 2 3 16,67 (5)(9) 
(3) 3 3 20,33 (5)(8)(9) 
(4) 4 3 19,00 (5)(8)(9) 
(5) 5 3 4,00 (1)(2)(3)(4)(6)(7) 
(6) 6 3 18,67 (5)(8)(9) 
(7) 7 3 18,33 (5)(8)(9) 
(8) 8 3 8,00 (1)(3)(4)(6)(7) 
(9) 9 3 3,00 (1)(2)(3)(4)(6)(7) 
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Table 5.5: % of cell viability in CHO-K1 cells incubated with 50 µg/ml AuNPs for 4 hours followed by 4 
Gy X-ray radiation. Kruskal-Wallis test was used to determine the significant difference between the control 
means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 16,1376 
Corrected for ties  Ht 16,3219 
Degrees of Freedom (DF) 8 
Significance level P = 0,037998 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 18,50 (5)(9) 
(2) 2 3 22,00 (5)(9) 
(3) 3 3 15,33 (5)(9) 
(4) 4 3 17,50 (5)(9) 
(5) 5 3 5,00 (1)(2)(3)(4)(6)(8) 
(6) 6 3 16,67 (5)(9) 
(7) 7 3 12,50 (9) 
(8) 8 3 16,50 (5)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
 
Table 5.6: % of cell viability in CHO-K1 cells incubated with 50 µg/ml AuNPs for 24 hours. Kruskal-
Wallis test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 21,7169 
Corrected for ties  Ht 21,7968 
Degrees of Freedom (DF) 8 
Significance level P = 0,005307 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 23,50 (3)(4)(5)(7)(8)(9) 
(2) 2 3 20,17 (4)(5)(8)(9) 
(3) 3 3 16,50 (1)(5)(8)(9) 
(4) 4 3 13,17 (1)(2)(5)(6)(9) 
(5) 5 3 4,50 (1)(2)(3)(4)(6)(7) 
(6) 6 3 22,33 (4)(5)(7)(8)(9) 
(7) 7 3 14,67 (1)(5)(6)(9) 
(8) 8 3 8,67 (1)(2)(3)(6) 
(9) 9 3 2,50 (1)(2)(3)(4)(6)(7) 
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Table 5.7: % of cell viability in BEnd5 cells incubated with 50 µg/ml AuNPs for 4 hours. Kruskal-Wallis 
test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 23,0476 
Corrected for ties  Ht 23,1040 
Degrees of Freedom (DF) 8 
Significance level P = 0,003233 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 12,00 (2)(3)(4)(5)(9) 
(2) 2 3 22,67 (1)(5)(6)(7)(8)(9) 
(3) 3 3 21,67 (1)(5)(6)(7)(8)(9) 
(4) 4 3 24,33 (1)(5)(6)(7)(8)(9) 
(5) 5 3 5,00 (1)(2)(3)(4)(7)(8) 
(6) 6 3 10,33 (2)(3)(4)(9) 
(7) 7 3 14,67 (2)(3)(4)(5)(9) 
(8) 8 3 13,33 (2)(3)(4)(5)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
 
Table 5.8: % of cell viability in BEnd5 cells incubated with 50 µg/ml AuNPs for 4 hours followed by 4 Gy 
X-ray radiation. Kruskal-Wallis test was used to determine the significant difference between the control 
means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 16,2275 
Corrected for ties  Ht 16,2573 
Degrees of Freedom (DF) 8 
Significance level P = 0,038842 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 13,00 (9) 
(2) 2 3 18,50 (5)(9) 
(3) 3 3 20,83 (5)(9) 
(4) 4 3 17,67 (5)(9) 
(5) 5 3 5,00 (2)(3)(4)(6)(7) 
(6) 6 3 19,67 (5)(9) 
(7) 7 3 15,50 (5)(9) 
(8) 8 3 13,83 (9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
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Table 5.9: % of cell viability in BEnd5 cells incubated with 50 µg/ml AuNPs for 24 hours. Kruskal-Wallis 
test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 22,8915 
Corrected for ties  Ht 22,9265 
Degrees of Freedom (DF) 8 
Significance level P = 0,003460 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 9,00 (2)(3)(7)(8)(9) 
(2) 2 3 23,67 (1)(4)(5)(6)(7)(9) 
(3) 3 3 24,67 (1)(4)(5)(6)(7)(8)(9) 
(4) 4 3 14,33 (2)(3)(5)(9) 
(5) 5 3 5,00 (2)(3)(4)(6)(7)(8) 
(6) 6 3 13,50 (2)(3)(5)(9) 
(7) 7 3 15,17 (1)(2)(3)(5)(9) 
(8) 8 3 18,67 (1)(3)(5)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
 
 
Table 5.10: % of cell viability in MCF-7 cells incubated with 50 µg/ml AuNPs for 4 hours. Kruskal-Wallis 
test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 23,0476 
Corrected for ties  Ht 23,1040 
Degrees of Freedom (DF) 8 
Significance level P = 0,003233 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 12,00 (2)(3)(4)(5)(9) 
(2) 2 3 22,67 (1)(5)(6)(7)(8)(9) 
(3) 3 3 21,67 (1)(5)(6)(7)(8)(9) 
(4) 4 3 24,33 (1)(5)(6)(7)(8)(9) 
(5) 5 3 5,00 (1)(2)(3)(4)(7)(8) 
(6) 6 3 10,33 (2)(3)(4)(9) 
(7) 7 3 14,67 (2)(3)(4)(5)(9) 
(8) 8 3 13,33 (2)(3)(4)(5)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
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Table 5.11: % of cell viability in MCF-7 cells incubated with 50 µg/ml AuNPs for 4 hours followed by 4 
Gy X-ray radiation. Kruskal-Wallis test was used to determine the significant difference between the control 
means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 24,9101 
Corrected for ties  Ht 24,9405 
Degrees of Freedom (DF) 8 
Significance level P = 0,001591 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 18,00 (2)(3)(5)(6)(7)(8)(9) 
(2) 2 3 25,00 (1)(4)(5)(6)(7)(8)(9) 
(3) 3 3 23,33 (1)(4)(5)(6)(7)(8)(9) 
(4) 4 3 19,67 (2)(3)(5)(6)(7)(8)(9) 
(5) 5 3 4,33 (1)(2)(3)(4)(6)(7)(8) 
(6) 6 3 14,00 (1)(2)(3)(4)(5)(8)(9) 
(7) 7 3 11,00 (1)(2)(3)(4)(5)(9) 
(8) 8 3 8,00 (1)(2)(3)(4)(5)(6)(9) 
(9) 9 3 2,67 (1)(2)(3)(4)(6)(7)(8) 
 
 
Table 5.12: % of cell viability in MCF-7 cells incubated with 50 µg/ml AuNPs for 24 hours. Kruskal-Wallis 
test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation 
Factor codes AuNPs 
Sample size 27 
Test statistic 24,3492 
Corrected for ties  Ht 24,3790 
Degrees of Freedom (DF) 8 
Significance level P = 0,001979 
 
Factor n Average Rank Different (P<0,05) 
from factor nr 
(1) 1 3 26,00 (2)(3)(4)(5)(6)(7)(8)(9) 
(2) 2 3 19,33 (1)(4)(5)(7)(8)(9) 
(3) 3 3 20,33 (1)(4)(5)(7)(8)(9) 
(4) 4 3 12,33 (1)(2)(3)(5)(6)(9) 
(5) 5 3 4,00 (1)(2)(3)(4)(6)(7)(8) 
(6) 6 3 20,33 (1)(4)(5)(7)(8)(9) 
(7) 7 3 12,33 (1)(2)(3)(5)(6)(9) 
(8) 8 3 8,33 (1)(2)(3)(5)(6)(9) 
(9) 9 3 3,00 (1)(2)(3)(4)(6)(7)(8) 
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Table 5.13: % of cell viability in MCF-10A cells incubated with 50 µg/ml AuNPs for 4 hours. Kruskal-
Wallis test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation  
Factor codes AuNPs 
Sample size 27 
Test statistic 23,0476 
Corrected for ties  Ht 23,1040 
Degrees of Freedom (DF) 8 
Significance level P = 0,003233 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 12,00 (2)(3)(4)(5)(9) 
(2) 2 3 22,67 (1)(5)(6)(7)(8)(9) 
(3) 3 3 21,67 (1)(5)(6)(7)(8)(9) 
(4) 4 3 24,33 (1)(5)(6)(7)(8)(9) 
(5) 5 3 5,00 (1)(2)(3)(4)(7)(8) 
(6) 6 3 10,33 (2)(3)(4)(9) 
(7) 7 3 14,67 (2)(3)(4)(5)(9) 
(8) 8 3 13,33 (2)(3)(4)(5)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
 
 
Table 5.14: % of cell viability in MCF-10A cells incubated with 50 µg/ml AuNPs for 4 hours followed by 4 
Gy X-ray radiation. Kruskal-Wallis test was used to determine the significant difference between the control 
means and experimental groups. 
Data % Proliferation 
Factor codes AuNPs 
Sample size 27 
Test statistic 21,2884 
Corrected for ties  Ht 21,3209 
Degrees of Freedom (DF) 8 
Significance level P = 0,006342 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 20,00 (4)(5)(6)(8)(9) 
(2) 2 3 16,83 (5)(9) 
(3) 3 3 22,67 (4)(5)(6)(8)(9) 
(4) 4 3 11,67 (1)(3)(7)(9) 
(5) 5 3 5,00 (1)(2)(3)(6)(7) 
(6) 6 3 12,67 (1)(3)(5)(7)(9) 
(7) 7 3 23,50 (4)(5)(6)(8)(9) 
(8) 8 3 11,67 (1)(3)(7)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
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Table 5.15: % of cell viability in MCF-10A cells incubated with 50 µg/ml AuNPs for 24 hours. Kruskal-
Wallis test was used to determine the significant difference between the control means and experimental groups. 
Data % Proliferation 
Factor codes AuNPs 
Sample size 27 
Test statistic 24,6217 
Corrected for ties  Ht 24,6971 
Degrees of Freedom (DF) 8 
Significance level P = 0,001749 
 
Factor n Average Rank Different (P<0,05) from factor nr 
(1) 1 3 15,50 (3)(5)(6)(7)(8)(9) 
(2) 2 3 17,00 (3)(5)(6)(7)(8)(9) 
(3) 3 3 23,00 (1)(2)(4)(5)(7)(8)(9) 
(4) 4 3 18,17 (3)(5)(6)(7)(8)(9) 
(5) 5 3 5,00 (1)(2)(3)(4)(6)(7)(8) 
(6) 6 3 26,00 (1)(2)(4)(5)(7)(8)(9) 
(7) 7 3 10,33 (1)(2)(3)(4)(5)(6)(9) 
(8) 8 3 9,00 (1)(2)(3)(4)(5)(6)(9) 
(9) 9 3 2,00 (1)(2)(3)(4)(6)(7)(8) 
 
 
 
 
 
 
 
 
 
 
